Document:

EX-10.7

 Exhibit 10.7 

***Text Omitted and Filed Separately 

with the Securities and Exchange Commission. 

Confidential Treatment Requested 

Under 17 C.F.R. Sections 200.80(b)(4) 

and 240.24b-2. 

DATED THIS 10th DAY OF OCTOBER 2016 

Between 
 NANYANG TECHNOLOGICAL
UNIVERSITY 
 And 
 ASLAN
PHARMACEUTICALS PTE LTD 
  
  

 
 LICENSING AND RESEARCH
COLLABORATION AGREEMENT 
  
  

 

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
 THIS AGREEMENT is entered into on
10th day of October 2016 between: 
  

	(1)	NANYANG TECHNOLOGICAL UNIVERSITY, located at 50 Nanyang Avenue, Singapore 639798, and acting through its School of Biological Sciences (“NTU”); 

And 
  

	(2)	ASLAN PHARMACEUTICALS PTE LTD, a company incorporated in Singapore (UEN: 201007695N), having its address at UE Square (West Wing), 83 Clemenceau Avenue, #12-03, Singapore
239920 (“Company”). 

 WHEREAS: 
  

	(A)	The Company is interested in sponsoring a research project to be carried out by School of Biological Sciences on the terms and conditions of this Agreement. 

THEREFORE the Parties hereby agree as follows: 
  

	1.	DEFINITIONS 

  

	1.1.	In this Agreement and in the Schedules to this Agreement, unless the context otherwise requires, the following expressions shall have the following meanings: 

 

					
	“Affiliate”	  	-	  	means any corporation, company or other entity which:
			
		  		  	 (i)      is Controlled by the relevant Party;

			
		  		  	 (ii)    Controls the relevant Party; or

			
		  		  	 (iii)   is under common Control with the relevant Party.

			
		  		  	For this purpose, “Control” means (a) at least fifty percent (50%) of the controlled entity’s outstanding shares or ownership interest representing the right to make decisions for such entity are owned
or controlled, directly or indirectly, by the controlling entity, and/or (b) the controlling entity possesses, directly or indirectly, the power to influence the decision-making process, the direction of management and the policies of the
controlled entity.
			
	“Background IP”	  	-	  	means any IP owned and/or controlled by a Party, or which such Party has the necessary rights to use for or in the Research Project, and which was conceived or reduced to practice
either:

  

			
		  	Page 2 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

					
		  		  	 (a)    prior to the commencement of the work performed pursuant to the
Research Project, or
  

(b)    outside the scope of the work performed pursuant to the Research Project;

 

         and a non-exhaustive
list of the Background IP intended to be disclosed by each Party in connection with the Research Project is listed in Schedule 1, part 5.

			
	“Business Day”	  	-	  	means a day other than a Saturday, Sunday or a gazetted public holiday in Singapore.
			
	“Confidential Information”	  	-	  	means any device, materials, samples, software programmes, documents, data, graphics, specifications, technical information, or any other information, collectively referred to as “Information”, that is disclosed
by either a Party or a Party’s Affiliate or on their behalf (“Discloser”) to the other Party (“Recipient”) in connection with the Research Project and/or this Agreement, whether oral, written, visual or
otherwise, or hard or electronic soft copy, other than as specified in clause 6.4.
			
	“Effective Date”	  	-	  	means the date first written above.
			
	“Intellectual Property” or ”IP”	  	-	  	means Confidential Information, Know-how, patents, patentable inventions, patent applications, utility models, copyright, design rights, trademarks, rights in data, database rights,
semiconductor layout rights, rights relating to computer software, and any other industrial or intellectual property rights, registrable, registered or otherwise.
			
	“IP Applications”	  	-	  	means any patent application, division, continuation or continuation-in-part, and any patent issued thereon or reissue or extension thereof, and any
other form of application for registration of copyrights, trademarks, designs and other IP rights relating to the relevant Project IP.
			
	“IP Expenses”	  	-	  	means all actual and out-of-pocket costs and expenses (including legal and other professional fees, Goods and Services Tax, other applicable taxes,
and stamp duties) in relation to the preparation, filing, prosecution and maintenance of the relevant IP Applications.

  

			
		  	Page 3 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

					
	“IP Lead Party”	  	-	  	means the Party appointed pursuant to Clause 7.4(a) of this Agreement to take the lead in the preparation, filing, prosecution and maintenance of the relevant IP Applications in accordance with the terms of this
Agreement.
			
	“Know-how”	  	-	  	means any methods, techniques, processes, discoveries, inventions, innovations, unpatentable processes, technical information, specifications, recipes, formulae, designs, plans, documentation, drawings, data and other
technical information and identified in a tangible form.
			
	“Major Territory”	  	-	  	means USA, those countries constituting the EU as at the Effective Date, UK, Japan, or China.
			
	“NTUitive”	  	-	  	means Nanyang Technological University — NTUitive Pte Ltd (Company Registration No. 199502518G), a wholly-owned subsidiary company of NTU which manages and commercialises IP for NTU.
			
	“Parties”	  	-	  	means NTU and the Company collectively, and a ”Party” means any one of them.
			
	“Project IP”	  	-	  	means any IP created in the course of or resulting from the Research Project that fall within the deliverables of the Research Project as set out in Schedule 1.
			
	“Research Project”	  	-	  	means the research project titled “Generation of domain antibodies for therapeutic applications” to be carried out under this Agreement, which details are set out in Schedule 1, as may be amended from time
to time in accordance with this Agreement.
			
	“Term”	  	-	  	means the period of this Agreement as specified in Clause 3 of this Agreement.

  

	1.2.	In this Agreement, except where the context indicates to the contrary: 

  

	 	a)	“person” includes any individual, body corporate, joint venture, trust, agency or other body; 

  

	 	b)	words importing the singular shall include the plural and vice versa and words denoting a given gender shall include each other gender; 

 

	 	c)	headings are inserted for ease of reference only and shall not affect the interpretation of this Agreement; 

  

	 	d)	references to clauses or sub-clauses shall have reference to clauses or sub-clauses of this Agreement; and 

  

			
	***Confidential Treatment Requested	  	Page 4 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	 	e)	all schedules and attachments to this Agreement form part of this Agreement. 

  

	2.	STATEMENT OF WORK 

  

	2.1.	The Parties agree to collaborate on the Research Project and shall use reasonable endeavours to carry out in a diligent manner those parts of the Research Project allocated to it, in accordance with the details
specified in Schedule 1. The Parties recognise that the Research Project is research in nature and hence completion within the period of performance or the achievement of the deliverables or milestones specified in Schedule
1 cannot be guaranteed. 

  

	2.2.	The Parties are committed to maintaining the highest standards of research integrity and the responsible conduct of research, as defined in the Singapore Statement on Research Integrity
(www.singaporestatement.org/statement.html). The Parties agree to cooperate in investigation(s) which result from any accusations of research misconduct and malpractice arising from the Research Project. 

 

	3.	TERM OF AGREEMENT 

  

	3.1.	This Agreement shall come into force on the Effective Date and shall continue for a period of one (1) year (the “Term”) unless terminated earlier in accordance with the terms of this Agreement.
Notwithstanding the foregoing, this Agreement may be extended by mutual written agreement of the Parties. 

  

	4.	PRINCIPAL INVESTIGATOR & GOVERNANCE 

  

	4.1.	The Research Project shall be supervised and coordinated by Professor [...***...] of NTU (hereinafter referred to as the “NTU Principal Investigator” or “NTU PI”), and
[...***...] for the Company (hereinafter referred to as the “Company Principal Investigator” or “Company PI”). 

  

	4.2.	If, for any reason, the NTU PI or the Company PI is unable to continue to serve as the NTU PI or as the Company PI under the Research Project, and, after reasonable efforts have been used to find one, a successor
acceptable to the Parties is not available, this Agreement may be terminated by any of the Parties upon at least [...***...] notice, subject to the prior approval of the JDC, which approval shall not be unreasonably withheld, and the
provisions of Clause 11 shall apply. Where the NTU PI is unable to continue to serve as the NTU PI for the Research Project, the Chair of the School of Biological Sciences, or his designate, shall replace the NTU PI on the JDC subject to this
Clause 4.2. 

  

	4.3.	The Company and NTU shall establish a joint development committee (“Joint Development Committee” or “JDC”) to oversee and execute the plan for the Research Project (“Project
Plan”) the current version of which as at execution of this Agreement is set out in Schedule 1. The JDC will at all times include two (2) representatives from each of the Company and NTU, selected by such Party, and one representative
from NTU shall be the NTU PI unless the Parties via the JDC agree otherwise, and one representative from ASLAN shall be the Company PI unless the Parties via the JDC agree otherwise. It is anticipated that membership of the JDC may change over the
course of the Research Project as needed to ensure sufficient expertise for execution of the then-current Project Plan. 

  

			
	***Confidential Treatment Requested	  	Page 5 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	4.4.	The JDC will meet regularly (at least [...***...]), either in person or by tele/video conference, according to a mutually agreed schedule; and on an ad hoc basis, as necessary. Among matters the JDC will confer
and decide on, are proposed changes to the Project Plan; for the avoidance of doubt any changes to the Project Plan are subject to JDC approval. Decisions of the JDC shall be made by unanimous vote, with each JDC member having one vote. In the event
that the votes required to approve a decision cannot be reached, then the issue will be referred for resolution in accordance with Clause 16. The JDC shall prepare written minutes of each JDC meeting and a written record of all JDC decisions,
whether made at a JDC meeting or otherwise and promptly circulate a copy to JDC members. 

  

	5.	RESEARCH PROJECT FUNDING 

  

	5.1.	The Parties shall provide the funding and/or contributions to the Research Project in accordance with Schedule 1. 

  

	6.	CONFIDENTIAL INFORMATION 

  

	6.1.	Each Recipient agrees to use the Discloser’s Confidential Information only for the purposes of the Research Project and/or this Agreement, unless otherwise expressly agreed to in writing by the Discloser.

  

	6.2.	Each Recipient shall use the same degree of care regarding the Confidential Information as it uses in protecting and preserving its own confidential information of like kind to avoid disclosure or dissemination thereof,
but in no event less than a reasonable degree of care. 

  

	6.3.	Each Recipient agrees to make the Discloser’s Confidential Information available only to those of its Affiliates, employees, officers, directors, legal or professional advisors, or students
(“Representatives”) who have a need to know the same for the purposes of the Research Project and /or this Agreement and who are bound by obligations of confidentiality. The Recipient shall not disclose the Confidential Information
to any third party except for any third party Representatives as provided herein. 

  

	6.4.	Each Party agrees that the obligations of confidentiality contained herein shall not apply to any Information which: 

  

	 	(i)	was publicly available prior to the date of disclosure under this Agreement or becomes publicly available thereafter through no wrongful act or omission on the Recipient’s part; 

 

	 	(ii)	was known to the Recipient prior to the date of disclosure under this Agreement or becomes known to the Recipient thereafter, without restriction as to use or disclosure, from a third party having an apparent bona fide
right to disclose the Information, as evidenced by written records; 

  

	 	(iii)	is independently developed by the Recipient, as evidenced by written records; or 

  

	 	(iv)	is disclosed with the Discloser’s prior written consent. 

  

	6.5.	 Where the Recipient is required to disclose Confidential Information pursuant to an order of a court of competent
jurisdiction or by law, the Recipient may disclose such 

  

			
	***Confidential Treatment Requested	  	Page 6 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

	 	Confidential Information provided that the Recipient, if not legally prohibited from so doing, promptly notifies the Discloser as soon as it becomes aware of, and preferably before, such required disclosure, and
cooperates reasonably with efforts by the Discloser to contest or limit the scope of such order or legal requirement to disclose, or to make other provision (such as filing patent applications) to limit the effect of such disclosure.

  

	6.6.	The Parties agree that any breach of confidentiality under this Clause 6 may cause irreparable injury to the Discloser and monetary damages may not be an adequate remedy for such breach. Accordingly, the Discloser
shall be entitled to seek equitable relief against any such breach, including injunctions, and this shall be without prejudice to the Discloser’s other rights and remedies under law. 

 

	6.7.	The obligations of confidentiality set out in this Clause 6 shall survive for a period of [...***...] from the date of expiry or early termination of this Agreement. 

 

	7.	INTELLECTUAL PROPERTY AND LICENSE RIGHTS 

  

	7.1.	Each Party shall remain the owner or authorised user of all its Background IP and nothing in this Agreement, save as specifically provided for herein, shall be deemed to grant impliedly or otherwise, ownership of or
rights of use of such Background IP to the other Party. Each Party may, at its sole discretion, disclose its Background IP to the other Party for use in connection with the Research Project but such Background IP shall only be used by the other
Party for the purpose of the Research Project and for no other purpose. It is agreed that no Party shall be compelled to disclose any of its trade secrets or Confidential Information as part of its Background IP licensed hereunder.

  

	7.2.	All rights, interests and title to the Project IP shall be [...***...] by the Parties. 

  

	7.3.	The commercialisation of the NTU Background IP and of the Project IP shall be governed by the following provisions 

  

	 	a)	NTU hereby grants the Company an option to negotiate for a non-exclusive license (in a designated field of use, where appropriate) of the NTU Background IP and an exclusive
license of the Project IP (the “Option”) on commercial terms and conditions based on and comprising all the terms set out in Schedule 2 which constitutes an integral part of this Agreement
(non-binding provisions therein remaining non-binding however). The Option may be exercised by the Company by service in writing to NTU of an “Exercise
Notice” at any time during the term of this Agreement and within [...***...] after expiry of the term of this Agreement (the “Option Period”). For the avoidance of doubt, it is agreed that Schedule 2 annexed hereto
substantially sets out all the terms and conditions of the Exclusive License Agreement that both NTU and the Company consider essential and fundamental, all other terms and conditions being merely ancillary. The Parties shall finalize and execute
such license agreement within [...***...] following receipt by NTU of the Exercise Notice (the “Negotiation Period”). 

  

	 	b)	If the Option is not exercised by the Company during the Option Period, NTU shall not have any further obligation to the Company in this regard. 

  

			
	***Confidential Treatment Requested	  	Page 7 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

	 	c)	If the Option is exercised by the Company, it is hereby agreed that upon the grant of the exclusive licence in the relevant Project IP to the Company:- 

 

	 	(i)	All and any decisions on the filing of any IP Application to protect the relevant Project IP shall be at the Company’s sole discretion and the Company shall coordinate with NTU as to the IP Applications which it
wishes to file for such Project IP. The Company shall be responsible for managing the filings, prosecution and maintenance of the IP Applications. The Company shall keep NTU informed of the status of the IP Applications from time to time. NTU shall
do all such other acts and things as may be necessary as the Company may reasonably request, at the Company’s cost and expense, to assist or enable the Company to maintain the IP Applications. The Company shall further ensure compliance with
all applicable Singapore and other patent laws and regulations when filing the IP Applications, including obtaining any necessary national security clearances from the Intellectual Property Office of Singapore prior to any foreign filings of IP
Applications; 

  

	 	(ii)	The Company shall be responsible for all IP Expenses associated with such IP Applications. The Company shall further reimburse NTU for all IP Expenses for such IP Applications that may have been incurred by NTU before
the effective date of the grant of the exclusive commercialisation rights to the Company; and 

  

	 	(iii)	All such IP Applications shall be filed in the joint names of NTU and the Company as the joint owners thereof. 

  

	 	d)	If the Option in respect of the Project lP is not exercised by the Company during the Option Period, [...***...], subject to [...***...], but in the case of [...***...], subject to [...***...].
Where [...***...] pursuant to this Clause 7.3 (d) [...***...]. 

  

	7.4.	Subject to any exclusive commercialisation agreement entered into by the Parties pursuant to Clause 7.3 above, the Parties shall manage all IP Applications for the Project IP in accordance with the following provisions:

  

	 	a)	The Parties shall appoint the Company to be the IP Lead Party to take the lead in the preparation, filing, prosecution and maintenance of all such IP Applications in accordance with the terms of this Agreement.

  

	 	b)	[...***...] the filing of any such IP Applications. All such IP Applications shall be filed in the [...***...]. 

  

	 	c)	The IP Lead Party shall provide the other Party: 

  

	 	(i)	a copy of any draft of such IP Application sufficiently prior to filing to permit the other Party reasonable opportunity to review and make comments thereon; 

  

			
	***Confidential Treatment Requested	  	Page 8 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	 	(ii)	copies of all substantive communications received from patent offices with respect to such filings; and 

  

	 	(iii)	copies of all grants or certificates of registration of any such IP Applications. 

 The IP Lead
Party shall further ensure compliance with all applicable Singapore and other patent laws and regulations when filing the IP Applications, including obtaining any necessary national security clearances from the Intellectual Property Office of
Singapore prior to any foreign filings of IP Applications. 
  

	 	d)	The Parties shall [...***...] in relation to such IP Applications. The IP Lead Party shall maintain adequate records showing all such IP Expenses incurred. In the event that the IP Lead Party anticipates the
possibility of any extraordinary expenditure of more than [...***...] in relation to any single event arising from the preparation, filing, prosecution or maintenance of any such IP Application, the IP Lead Party shall provide the other Party
with full particulars and shall discuss with the other Party a mutually acceptable course of action prior to incurring such expenditure. The other Party shall pay for its share of the IP Expenses after receiving an invoice for such IP Expenses.

  

	 	e)	The Parties agree to give each other reasonable assistance in obtaining the IP protection for the Project IP and in the preparation, filing, prosecution and maintenance of any such IP Application filed and shall cause
to be executed all assignments and other instruments and documents as may be necessary or appropriate. 

  

	 	f)	The IP Lead Party shall not abandon the prosecution or maintenance of any such IP Application without the prior written consent of the other Party, such consent not to be unreasonably withheld. 

 

	 	g)	In the event that one Party elects not to seek or maintain any such IP Application in respect of a particular country or not to share in the IP Expenses thereof (the
“Non-Electing Party”), the Non-Electing Party shall notify the other Party of such decision (the “Notification”). 

 

	 	(i)	Notwithstanding the Notification, the Non-Electing Party shall continue to be liable to pay for its share of the IP Expenses incurred or committed or arising from work carried out
prior to the date of such Notification. 

  

	 	(ii)	The other Party (the “Electing Party”) shall have the right to seek or maintain such IP Application in such country in both Parties’ name at the Electing Party’s own expense, and shall have
full control over the prosecution and maintenance thereof. 

  

	 	(iii)	The Electing Party shall have the right to [...***...] the IP Application in such country and to [...***...]. 

  

	 	(iv)	The Non-Electing Party shall cease to have any rights: 

  

	 	(1)	to [...***...] such IP Application in such country; and 

  

	 	(2)	to [...***...] such IP Application in such country. 

  

			
	***Confidential Treatment Requested	  	Page 9 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	7.5.	For the purposes of this Clause, the Company agrees that: 

  

	 	a)	NTU may assign and/or transfer to NTUitive all of NTU’s legal rights to and ownership in the Project IP, and the Company agrees that NTU shall be so entitled to assign and/or transfer such rights and ownership
without further reference to the Company, or any obligation to obtain the Company’s consent; and 

  

	 	b)	NTU may novate or assign all or any of its rights and/or obligations under Clauses 7.3 and 7.4 above to NTUitive and in such case and where applicable, references to NTU in Clauses 7.3 and 7.4 shall be deemed to refer
to NTUitive. 

  

	7.6.	Each Party shall have the unfettered right to use the Project IP for its academic, research, development and other non-commercial purposes. 

 

	8.	PUBLICATIONS 

  

	8.1.	NTU and the Company have the right to publish in any journal, thesis, or dissertation, or present at any national, international or professional meeting, the findings, methods and results derived from the Research
Project, subject to the provisions of Clause 6 and Clauses 8.2 to 8.4 below. 

  

	8.2.	The Party who intends to publish or present (the “Publishing Party”) shall furnish a copy of such proposed publication or presentation to the other Party (the
“Non-Publishing Party”) at least [...***...] days before such publication or presentation and then the Non-Publishing Party shall, within
[...***...] of receipt of the proposed publication or presentation, forward its written objections to the Publishing Party if it determines that its Confidential Information or patentable subject matter may be disclosed. If no written
objection is made within the stipulated time, the Publishing Party shall be free to proceed with the publication or presentation. 

  

	8.3.	Confidential Information that is governed by Clause 6 identified by the Non-Publishing Party shall be deleted from the proposed publication or presentation. Notwithstanding the
aforementioned, in the event that a student needs to publish or present results of his/her work under the Research Project as part of his/her degree requirements: 

 

	 	a)	any deletion of Confidential Information should not affect the scientific and academic value of such student’s thesis, report, publication or presentation (“Degree Paper”); 

 

	 	b)	if the Publishing Party notifies the Non-Publishing Party in good faith that it is necessary for the student to include Confidential Information in such Degree Paper for purposes
connected with his/her degree requirements, then the Non-Publishing Party will consent to such inclusion, on the express condition that the Publishing Party undertakes to ensure that (i) the student
discloses copies of, and/or presents the content of, the Degree Document strictly only to persons who need to know the same for such purposes and who have agreed to be bound by obligations of confidentiality in respect of the Confidential
Information; and (ii) the Degree Paper is not placed in the public domain without the Non-Publishing Party’s prior written consent. 

 

	8.4.	 In the event that the Non-Publishing Party objects to any such
publication or presentation on the basis that the same would disclose patentable subject matter and would like an IP Application filed, the Non-Publishing Party shall withhold such

  

			
	***Confidential Treatment Requested	  	Page 10 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

	 	publication or presentation for a period of up to [...***...] from the date of receipt of such objection, or such additional period as may be reasonably requested, in order for the relevant IP Application(s) to be
filed with respect to such patentable subject matter. 

  

	9.	WARRANTIES AND DISCLAIMERS OF LIABILITY 

  

	9.1.	All IP, findings, results, reports and materials provided by any Party under this Agreement are provided “as-is” and without any representation or warranty, express or
implied, including without limitation, any implied warranty of merchantability or fitness for any particular purpose, or any warranty that any use thereof will not infringe or violate any patent or other proprietary rights of any other person.

  

	9.2.	Each Party shall be solely responsible and liable for (i) the acts and omissions of its respective directors, agents, contractors and employees; and (ii) its use of the Project IP, or findings, results,
reports or materials from the Research Project. 

  

	9.3.	No Party shall be liable for any loss, whether indirect, consequential, punitive or incidental, or any special loss or damage (including loss of profits, loss of use, and loss of production) however caused (and whether
arising out of contract, strict liability, or tort or under any legal or equitable theory of liability) which the other Party may suffer arising from any defect, error, fault or failure to perform with respect to any Background IP or Project IP,
except to the extent where the same is caused by the gross negligence, dishonesty or wilful misconduct of that Party. 

  

	9.4.	In no event shall any Party be liable to the other Party for any loss of profits, loss of goodwill, loss of use, loss of production or business interruption costs, or any type of indirect, special, consequential or
incidental loss or damages suffered by the other Party arising from any breach of this Agreement whether or not the Party has been advised of the possibility of such damage, except to the extent where the same is caused by the gross negligence,
dishonesty or wilful misconduct of that Party. 

  

	9.5.	Notwithstanding anything to the contrary in this Agreement, NTU’s liability for any cause whatsoever related to the subject matter of this Agreement and regardless of the form of action, whether in contract or in
tort, including negligence, shall be limited to the cash funding provided by the Company to NTU for the performance of the Research Project, except to the extent where the same is caused by the gross negligence, dishonesty or wilful misconduct of
NTU. 

  

	10.	TERMINATION 

  

	10.1.	A Party (hereinafter the “Terminating Party”) may terminate this Agreement:- 

  

	 	a)	in the event of the other Party (the “Defaulting Party”) being in breach of any material term of this Agreement which is either incapable of rectification or which is not rectified within
[...***...] of written notice given by the Terminating Party; or 

  

	 	b)	in the event of the other Party: 

  

	 	(i)	having a receiver appointed to any of its assets; or 

  

	 	(ii)	compounding with its creditors; or 

  

			
	***Confidential Treatment Requested	  	Page 11 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

	 	(iii)	entering into liquidation other than for the purposes of amalgamation or reconstruction. 

  

	10.2.	Either Party may terminate this Agreement with [...***...] written notice given to the other Party if the Parties cannot agree to proceed with the Research Project at any decision point as set out in the project
plans in Schedule 1. 

  

	11.	CONSEQUENCES OF TERMINATION 

  

	11.1.	Where this Agreement is terminated in accordance with Clause 4.2, Clause 10.2 or Clause 13.3, the Parties shall use their best endeavours to wind up the work carried out in relation to the Research Project in an orderly
fashion and where applicable to complete such outstanding work during the relevant action periods. NTU shall be entitled to claim from the Company all costs incurred by NTU that would otherwise have been covered by the funding from the Company,
including for non-cancellable commitments and NTU resources utilised, in the performance of the Research Project up to and including the date of termination, provided that the total funding amount shall not be
exceeded. NTU shall reimburse to the Company any unutilised funds. 

  

	11.2.	Where this Agreement is terminated in accordance with Clause 10.1.a) the Terminating Party shall be relieved of its obligations under the Research Project and shall have no liability whatsoever to the Defaulting Party
in respect of such termination. 

  

	11.3.	The termination of this Agreement shall not affect any rights that shall have accrued to any Party prior to such termination. 

  

	11.4.	In addition to such provisions which survive the termination of this Agreement by operation of law, the provisions of Clauses 6, 7, 8, 9, 11, 12, and 14 to 21 shall continue in force in accordance with their terms,
notwithstanding the termination of this Agreement for any reason. 

  

	12.	ASSIGNMENT 

  

	12.1.	Except as provided for under this Agreement, and to Affiliates, no Party may assign all or any of its rights or obligations under this Agreement without the prior written consent of the other Party. 

 

	13.	FORCE MAJEURE 

  

	13.1.	No Party shall be liable for any failure to perform its obligations under this Agreement if the failure results from events beyond the reasonable control of any of the Parties. For the purpose of this Agreement, such
events shall include, but not necessarily be limited to, strikes, lock-outs or other labour disputes, civil disturbances, actions or inactions of government authorities or suppliers, epidemics, wars, embargoes, acts of God or other catastrophes
(“Force Majeure Event”). 

  

	13.2.	The respective obligations of a Party hereunder shall be suspended during the time and to the extent that such Party is prevented from complying therewith by a Force Majeure Event provided that such Party shall have
given written notice thereof, specifying the nature and details of such event and the probable extent of the delay, to the other Party. 

  

			
	***Confidential Treatment Requested	  	Page 12 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

	13.3.	In case of a Force Majeure Event the time for performance required by a Party under this Agreement shall be extended for any period during which the performance is prevented by the event. However, the other Party may
terminate this Agreement by notice in writing if such an event which prevents performance continues for more than [...***...]. 

  

	14.	USE OF NAMES 

  

	14.1.	No Party shall use the name of the other Party for any purpose whether in relation to any advertisement or other form of publicity without obtaining the prior written consent of the other Party, not to be unreasonably
withheld or delayed. 

  

	14.2.	Notwithstanding the generality of Clause 14.1 the Parties may notify third parties of the fact that this Agreement is in effect. 

  

	15.	NOTICES 

  

	15.1.	Any notice to be given by a Party to this Agreement shall be in writing and shall be deemed duly served if delivered personally or sent by prepaid registered post to the addressee at the address or at such other address
as the Party to be served may have notified the other Party for the purposes of this Agreement: 

  

			
	NTU:	 	
	
	 For technical matters relating to the Research Project:

	 School of Biological Sciences

	 Nanyang Technological University

	 61 Biopolis Drive, Singapore 135673

	 Attn: [...***...]

	
	 For Contract Matters: 

	 Legal & Secretarial Office

	 Nanyang Technological University

	 Innovation Centre Block 1, Unit 208

	 16 Nanyang Drive, Singapore 637722

	 Attn: Research Contracts (Ref: RCA-16/256)

	
	 For Intellectual Property Matters: 

	 Nanyang Technological University — NTUitive Pte Ltd

	 Innovation Centre Block 1, Unit 109

	 16 Nanyang Drive, Singapore 637722

	 Attn: CEO (Ref: RCA-16/256)

		
	Company:	 	
	
	 Asian Pharmaceuticals Pte Ltd

	 UE Square (West Wing), 83 Clemenceau Avenue, #12-03, Singapore
239920

	 Attn: General Counsel

  

	15.2.	Any notice given pursuant to Clause 15.1 shall be deemed to have been received: 

  

	 	a)	in the case of delivery by hand, when delivered; or 

  

	 	b)	in the case of sending by post: 

  

	 	(i)	where posted in the country of the addressee, on the third Business Day following the day of posting; and 

  

	 	(ii)	where posted in any other country, on the seventh Business Day following the day of posting; or 

  

			
	***Confidential Treatment Requested	  	Page 13 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	16.	DISPUTE RESOLUTION 

  

	16.1.	In the event of any difference or dispute arising between the Parties relating to the validity, interpretation, construction or performance of this Agreement, the Parties shall use their reasonable endeavours to settle
amicably such difference or dispute by consultation and negotiation. 

  

	16.2.	If such efforts taken under Clause 16.1 above fail, then the Parties may refer the matter to mediation in accordance with the rules and procedures of the [...***...]. 

 

	16.3.	If, and to the extent that, any dispute has not been settled pursuant to Clauses 16.1 and 16.2 above, then the dispute shall be referred to and finally resolved by arbitration in Singapore in accordance with the
[...***...] for the time being in force, which rules are deemed to be incorporated by reference to this Clause 16. The language of the arbitration shall be English. Any award made hereunder shall be final and binding upon the Parties hereto
and judgment on such award may be entered into by any court or tribunal having jurisdiction thereof. 

  

	17.	GOVERNING LAW 

  

	17.1.	This Agreement, including its validity and interpretation and the merits of any dispute or claim arising out of or relating to this Agreement, shall be governed by the laws of Singapore. 

 

	18.	CONTRACTS (RIGHTS OF THIRD PARTIES) ACT (CAP.53B) 

  

	18.1.	No person shall have any right pursuant to the Contracts (Right of Third Parties) Act (CAP.53B) to enforce any of the terms and conditions in this Agreement. 

 

	19.	COMPLIANCE WITH APPLICABLE LAWS 

  

	19.1.	The Parties shall comply at all times with any relevant laws, regulations, by-laws, rules and guidelines applicable to it in the carrying out of the Research Project, including
any Personal Data (as defined below) or data privacy laws. 

 Where a Party (the “Disclosing Party”) will be
disclosing Personal Data to the other Party (the “Receiving Party”) and prior to disclosing any Personal Data to the Receiving Party, the Disclosing Party shall obtain consent from the individual whose Personal Data is being
disclosed (the “Data Subject”), to permit the Receiving Party to collect, use and/or disclose the Data Subject’s Personal Data for the purposes of the Research Project and/or this Agreement. The Receiving Party will use the
Personal Data solely for the purposes for which the Disclosing Party disclosed the Personal Data 
 “Personal Data” shall
mean any data, whether true or not, about an individual who can (a) be identified from that data; or (b) from that data and other information to which the Receiving Party has or is likely to have access. 

 

	20.	ENTIRE AGREEMENT 

  

	20.1.	Unless otherwise expressly specified, this Agreement embodies the entire understanding between the Parties in respect of the Research Project and any prior or contemporaneous representations, either oral or written, are
hereby superseded. 

  

	20.2.	No amendments or changes to this Agreement shall be effective unless made in writing and signed by duly authorised representatives of the Parties. 

  

			
	***Confidential Treatment Requested	  	Page 14 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	21.	GENERAL 

  

	21.1.	Nothing in this Agreement shall create or be deemed to create, a partnership, or the relationship of principal and agent, between the Parties. 

 

	21.2.	No exercise, or failure to exercise, or delay in exercising any right power or remedy vested in any Party under or pursuant to this Agreement shall constitute a waiver by that Party of that or any other right, power or
remedy. 

  

	21.3.	In the event that any term, condition or provision of this Agreement is held to be a violation of any applicable law, statute or regulation, the same shall be deemed to be deleted from this Agreement and shall be of no
force and effect, and this Agreement shall remain in full force and effect as if such term, condition or provision had not originally been contained in this Agreement. Notwithstanding the above, in the event of any such deletion, the Parties shall
negotiate in good faith in order to agree on terms of a mutually acceptable and satisfactory alternative provision in place of the provision so deleted. 

  

	21.4.	The Parties shall co-operate with each other and execute and deliver to the other such instruments and documents and take such other action as may be reasonably requested from
time to time in order to carry out and confirm the rights and the intended purpose of this Agreement. 

  

	21.5.	Except as otherwise provided in this Agreement, the Parties shall bear their own costs of and incidental to the preparation, execution and implementation of this Agreement. 

 

	21.6.	The Parties may sign this Agreement in one (1) or more counterparts by the duly authorised representatives of the Parties, each of which constitutes an original and all of which taken together shall constitute the
Agreement. The Parties may sign and deliver this Agreement by facsimile or by emailed portable document format (“PDF”) document (or other mutually agreeable document format), and a reproduction of this Agreement with a Party’s
signature made by facsimile or PDF, sent by facsimile or email shall have the same effect as and be enforceable as a signed and delivered original version of this Agreement. 

  

			
		  	Page 15 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
 IN WITNESS WHEREOF the Parties have caused this Agreement to be executed on the
date first above written. 
  

									
	SIGNED by for and on behalf of 	  		  	SIGNED by for and on behalf of
			
	NANYANG TECHNOLOGICAL UNIVERSITY	  		  	ASLAN PHARMACEUTICALS PTE LTD
			
	 /s/ Peer Preiser
	  		  	 /s/ Carl Firth

	Name: Professor Peer Preiser	  		  	Name: CARL FIRTH
	Designation:	 	Chair School of Biological Sciences Nanang Technological University	  		  	Designation:	 	CEO
			
	In the presence of:	  		  	In the presence of:
			
	 /s/ Pär Nordlund
	  		  	 /s/ Isana Enpo

	Name: Pär Nordlund	  		  	Name: Isana Enpo
	Designation:	 	Professor	  		  	Designation:	 	Senior Business Development
		 		  		  	Director	 	

  

			
		  	Page 16 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
 SCHEDULE 1 

RESEARCH PROJECT 
 Title
:Generation of domain antibodies for therapeutic applications 
  

	1.	BACKGROUND I INTRODUCTION I OBJECTIVES AND SCOPE OF THE WORK 

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 17 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	2.    DELIVERABLES	

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 18 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	3.	CONTRIBUTIONS TO THE RESEARCH PROJECT / BUDGET 

  

	(a)	In-kind Contribution by NTU to the Research Project 

[...***...] 

  

			
	***Confidential Treatment Requested	  	Page 19 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

							
		
	
(b)      In-kind Contribution by the
Company to NTU to carry outthe Research Project
	  	 	[...***...]	 
			
		    		  	 	S$	 
	 (c)       Funding by the Company to NTU to
complete the 3research streams described in the research Project
	  			
			
		    	            [...***...]	  			
		    	Total Amount Payable*	  	 	255,000	 
	 	 
	[...***...]	  			

  

			
	***Confidential Treatment Requested	  	Page 20 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

	4.	PAYMENT SCHEDULE 

 The Company shall pay the Total Amount Payable of S$255,000
[...***...]in accordance with the following schedule of payment: 
  

											
		  		 	[...***...]	  	[...***...]	  	[ *** `]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  		  		  	
	 [...***...]
	  	 [...***...]
	 	[...***...]	  		  		  	
	 [...***...]
	  		 		  		  		  	
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  		 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  		 	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  		 		  	[...***...]	  		  	
	 [...***...]
	  		 		  		  	[...***...]	  	
	 Total for Project 1, 2 and 3
	  		 		  		  		  	255,000

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 21 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
  

	5.	BACKGROUND IP 

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 22 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
 SCHEDULE 2 

TERM SHEET 
 This term sheet (this
“Term Sheet”) describes the principal terms for the commercialization of specified Licensed Technology (as defined below). Other than as provided below under “Terms Confidential” and “Law” or in existing or future
written non-disclosure agreements: (a) this document represents only a summary of certain potential terms and is intended solely as a basis for further discussions; (b) this document is not intended
to and does not create any agreements, expectancies or legally binding obligations; and (c) all rights and obligations of the Parties, if any, will be subject to, without limitation, successful completion of due diligence by all Parties and
negotiation and execution of definitive transaction documents, including without limitation the License Agreement (as defined below). 
  

							
	1.	  	NTUitive	  	:	    	Nanyang Technological University — NTUitive Pte Ltd, a company incorporated in Singapore (UEN: 199502518G)
				
	2.	  	Licensee	  	:	    	Asian Pharmaceuticals Pte Ltd, a company incorporated in Singapore (UEN: 201007695N) .
				
	3.	  	License Grant	  	:	    	NTUitive will grant Licensee a non-exclusive license under the Licensed Technology with respect to the NTU Background IP and an exclusive license with respect to its share of the Project IP during the Term to develop, make, have
made, import into, use, offer for sale, sell and have sold Licensed Products in the Field of Application in the Territory, and to use the Licensed Technology for such purpose, on the terms of a License Agreement to be signed.
				
		  		  		    	Nothing in the License Agreement will prejudice NTU’s right to use, and to allow NTU staff members, employees and students to use, and/or to grant other third parties the rights to use, the Licensed Technology with respect to
the Background IP for academic, research and other non-commercial purposes.
				
	4.	  	NTU Background IP	  	:	    	The invention(s) as described in Annex 1, Part (a).
				
	5.	  	Project IP	  	:	    	“Project IP” shall have the meaning ascribed to it in Clause 1.1 of the RCA.
				
	6.	  	 Research
 Collaboration Agreement

or RCA
	  	 :
	    	The Licensing and Research Collaboration Agreement between Nanyang Technological University and the Licensee dated 10 October 2016 for the research project titled “Generation of domain antibodies for therapeutic
applications”.
				
	7.	  	Licensed Patents	  	:	    	The patents and patent applications in respect of the NTU Background IP and Project IP as listed in Annex 1, Part (b):

  

			
	***Confidential Treatment Requested	  	Page 23 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

							
		  		  		    	(i) all divisional, continuation or reissue applications of any such patent applications;
				
		  		  		    	(ii) all patents issuing from any of the foregoing applications;
				
		  		  		    	(iii) all reissues, re-examinations and extensions of any of the foregoing patents; and
				
		  		  		    	(iv) all patents and patent applications anywhere in the Territory that, at any time, claimed priority from or contained the same disclosure as any of the foregoing patent applications.
				
	8.	  	Licensed Proprietary Materials	  	:	    	Unpublished research and development information, technical information, manufacturing techniques, formulae, data, designs and other information in relation to the NTU Background IP and Project IP in the possession of NTUitive and
as listed in Annex 1, Part (c) to be transferred to Licensee pursuant to the License Agreement.
				
	9.	  	Licensed Technology	  	:	    	Licensed Patents and Licensed Proprietary Materials.
				
	10.	  	Licensed Products	  	:	    	Any product or service that:
				
		  		  		    	(i) the making, using, selling or import of which is covered by any claim of any patent under the Licensed Patents (treating for this purpose, any pending patents as if they had been issued); and/or
				
		  		  		    	(ii) incorporates or that is or was developed in whole or in substantial part through the use or application of any of the Licensed Proprietary Materials.
				
	11	  	Term	  		    	Save for early termination, the license rights granted will terminate, on a country-by-country basis, upon the later of (a) the last to expire of
any patents under the Licensed Patents; or (b) the end of a period of 20 years from the date of the first commercial sale of Licensed Product. Should the period referred to in part (a) expire prior to 20 years from the date of the first
commercial sale in a particular country or countries, the license in that country or those countries will be deemed a license to the Licensed Proprietary Materials.
				
	12.	  	Field of Use	  	:	    	All Fields
				
	13.	  	Territory	  	:	    	Worldwide.

  

			
		  	Page 24 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

							
	14.	  	Sub-Licenses	  	:	    	Licensee will have the right to grant sub-licenses of the Licensed Technology.
				
	15.	  	Licensee Performance Milestones	  	:	    	No licensee performance milestones will be included in the License Agreement
				
	16.	  	Financial Consideration	  	:	    	(i) Upfront License Fee, consisting of:
				
		  		  		    	 S$20,000 (non-refundable) for the non-exclusive license of NTU Background IP in the Field of Application

S$10,000 (non-refundable) for the exclusive license of NTU’s rights in the Project IP.

				
		  		  		    	The Licensee shall pay the non-refundable Upfront License Fee upon signing the License Agreement.
				
		  		  		    	(ii) Development Milestone Payments:
				
		  		  		    	Upon achievement of the following milestones events for any of the Licensed Products the Licensee shall pay NTUitive the following non-refundable sums.
				
		  		  		    	    (a)  [...***...]
				
		  		  		    	    (b)  [...***...]
				
		  		  		    	    (c)  [...***...]
				
		  		  		    	    (d)  [...***...]
				
		  		  		    	The Licensee shall notify NTUitive upon the occurrence of each milestone event above within [...***...] of such occurrence and shall pay the
				
		  		  		    	relevant Development Milestone Payment within [...***...] upon occurrence of the milestone.
				
		  		  		    	(ii) Royalties:
				
		  		  		    	(a) [...***...] of Net Sales for the first [...***...] of total Net Sales; and
				
		  		  		    	(b) [...***...] of Net Sales thereafter.
				
		  		  		    	The amounts stated above are exclusive of any applicable Singapore Goods and Services Tax (GST) payable by Licensee on such amounts.
				
		  		  		    	Accounting of Royalties will be on a calendar year basis.
	17.	  	Net Sales	  	:	    	The amount received for all sales, leases, or other transfers of Licensed Products by or for Licensee or its Sub-Licensees, to a third party who will be an end user of the Licensed Products,
less:

  

			
	***Confidential Treatment Requested	  	Page 25 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

							
				
		  		  		    	 (i)     customary trade, quantity or cash discounts and non-affiliated brokers’ or agents’ commissions actually allowed and taken;

				
		  		  		    	 (ii)    amounts repaid or credited by reason of rejection or
return;

				
		  		  		    	 (iii)   to the extent separately stated on purchase orders, invoices, or other
documents of sale, taxes levied on and/or other governmental charges made as to production, sale, transportation, delivery or use; and

				
		  		  		    	 (iv)   reasonable charges for delivery or transportation provided by third parties,
if separately stated (to the extent not paid by the third party customer).

				
		  		  		    	Net Sales also includes the fair market value of any non-cash consideration received by Licensee or its Sub-Licensee for the use, sale, lease, or
transfer of Licensed Products.
				
	18.	  	Accounts and Audit Rights	  	:	    	Licensee will deliver to NTUitive annual audited financial statements. NTUitive will have the right to inspect Licensee’s accounts and records bearing upon amount of royalties and other sums payable to NTUitive upon not less
than [...***...] prior written notice.
				
	19.	  	Patent Expenses and Management of Licensed Patents in relation to Project IP	  	:	    	All and any decisions on the filing of any patent application to protect the Project IP shall be at Licensee’s sole discretion and Licensee shall coordinate with NTUitive as to the patent applications which it wishes to file
for the Project IP.
				
		  		  		    	Licensee shall be responsible for all Patent Expenses associated with such patent applications. Licensee shall further reimburse NTUitive for all Patent Expenses for such patent applications that may have been incurred by NTUitive
before the effective date of the grant of the exclusive license rights to Licensee;
				
		  		  		    	All such patent applications shall be filed in the joint names of NTU and Licensee as the joint owners thereof.

  

			
	***Confidential Treatment Requested	  	Page 26 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

							
		  		  		    	Licensee will be responsible for managing the filings, prosecution and maintenance of all Licensed Patents for the Project IP in the Territory. Licensee will keep NTUitive informed of the status of the Licensed Patents from time to
time. NTUitive will do all such other acts and things as may be necessary as Licensee may reasonably request, at Licensee’s cost and expense, to assist or enable Licensee to maintain the Licensed Patents, and agrees to procure that NTU as
necessary does such acts and things as aforesaid.
				
	20.	  	Infringement of Licensed Patents by third parties	  	:	    	Licensee shall notify NTUitive in writing of any infringement, or suspected or threatened infringement, of any of the Licensed Patents that shall at any time come to its knowledge.
				
		  		  		    	While and as long as the license remains exclusive with respect to the Project IP, Licensee will be responsible for, after consultation with NTUitive, taking all appropriate steps (including all legal proceedings) as may be
necessary to prevent or restrain any infringement by a third party of any of the Licensed Patents in relation to the Project IP in the Field of Application and will be responsible for all costs and fees incurred by Licensee in the taking of any such
steps. Licensee is empowered to bring any such legal proceedings in its own name, or if required by law, jointly with NTUitive. Any award or settlement payment resulting from an action initiated by Licensee will be first used to reimburse all
documented out-of-pocket expenses incurred by both Parties in relation to such legal action, and thereafter paid to Licensee and will be deemed royalties received under
the license agreement.
				
		  		  		    	If Licensee decides not to or fails to take appropriate steps to prevent or restrain any infringement by any third party of any of the Licensed Patents in relation to the Project IP (but not otherwise), NTUitive will be entitled to
take action to prevent or restrain such infringement. NTUitive will be entitled to retain any award of damages or other compensation obtained as a result of any such action (including any proceedings) being taken by NTUitive. Licensee agrees to
provide reasonable assistance which NTUitive may require in any litigation including the execution of all necessary legal documents.
				
	 21.
	  	 Infringement of third

party rights
	  	 :
	    	If any proceedings are brought against Licensee on grounds that the use or exploitation by Licensee of any of the Licensed Technology infringes the rights

  

			
		  	Page 27 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

							
		  		  		    	of any third party, Licensee will notify NTUitive of the same. Licensee will have the exclusive control of the defense of such proceedings. NTUitive will not be liable for, and Licensee will indemnify NTUitive and NTU and keep
NTUitive and NTU indemnified against, all and any costs and expenses including consequential loss or damage, loss of profits or other economic loss suffered by Licensee in respect of such proceedings, save where such costs, expenses, losses and
damages are caused directly by the gross negligence or wilful misconduct of NTUitive and/or NTU, including the deliberate infringement of the intellectual property of any third party by NTUitive and/or NTU, in respect of the Licensed
Technology.
				
	22.	  	 Warranties and
 Liabilities
	  	:	    	Neither NTUitive nor NTU makes no warranties or representations, express or implied, including without limitation:
				
		  		  		    	 (i)     warranties of fitness for a particular purpose or
merchantability, satisfactory quality, reliability, accuracy or validity of the Licensed Technology or Licensed Products; or;

				
		  		  		    	 (ii)    the patentability of the Licensed Technology or Licensed Products or
of the enforceability of any Licensed Patents, if any; or

				
		  		  		    	 (iii)  that the Licensed Technology or Licensed Products are or will be free from
infringement of any patent or other rights of third parties, subject as provided in 21 above.

				
		  		  		    	Neither NTUitive nor NTU, nor any of their faculty members, scientists, researchers, employees, officers, trustees or agents, assume any responsibility for the use of the Licensed Technology by Licensee, or its Sub-Licensees, or any use, manufacture, specifications, sale or other dispositions of Licensed Products by or for Licensee or its Sub-Licensees, except to the extent where the
same is caused by the gross negligence, dishonesty or wilful misconduct of NTUitive and/or NTU.
				
		  		  		    	Neither NTUitive nor NTU will be liable to Licensee for any loss, damages, expenses, costs, damages or any other liability whatsoever which in any way relates to the use of the Licensed Technology by Licensee or its Sub-Licensees, or any use, manufacture, specifications, sale or other

  

			
		  	Page 28 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 

							
		  		  		    	dispositions of Licensed Products by or for Licensee or its Sub-Licensees, subject as provided in 21 above, except to the extent where the same is caused by the gross negligence, dishonesty or
wilful misconduct of NTUitive and/or NTU.
				
		  		  		    	Notwithstanding anything to the contrary, NTUitive’s total and cumulative liability under the license agreement, howsoever arising, will not exceed the total sum of monies paid by Licensee to NTUitive pursuant to the license
agreement, except to the extent where the same is caused by the gross negligence, dishonesty or wilful misconduct of NTUitive and/or NTU.
				
	23.	  	Indemnities and Insurance	  	:	    	Licensee will at all times indemnify, defend and hold harmless NTUitive and NTU against all and any loss, damages, expenses, costs, or damages, incurred by NTUitive or NTU, or for which NTUitive or NTU may become liable arising:
(a) out of any use of the Licensed Technology by Licensee or its Sub-Licensees, subject as provided in 21 above; or (b) out of any use, manufacture, sale, or other disposition of Licensed Products by
or for Licensee or its Sub-Licensees. Such indemnity and defense obligation will apply to any claims, including without limitation, infringement of third party intellectual property rights, personal injury,
and death or property damage, made by employees, subcontractors or agents of Licensee, as well as any member of the general public.
				
		  		  		    	Licensee will maintain adequate product liability insurance coverage and will ensure that NTUitive’s and NTU’s interest are noted on the policy. Licensee will supply NTUitive with a copy of such insurance policy on
request.
				
	24.	  	Law	  		    	Singapore law shall apply in all respects.
				
	25.	  	Terms Confidential	  		    	Licensee and NTUitive agree that the terms hereof and the nature of the contemplated transaction described herein shall not be disclosed to any third party. NTU shall not be considered as a third party for the purposes of this
clause.

  

			
	***Confidential Treatment Requested	  	Page 29 of 30

 LICENSING AND RESEARCH COLLABORATION AGREEMENT 

 
 ANNEX 1 

 

	(a)	Description of NTU Background IP (Non-Exclusive License)  

[...***...] 
  

	(b)	Licensed Patents 

 [...***...] 

 

	(c)	Licensed Proprietary Materials 

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 30 of 30

 ***Text Omitted and Filed Separately 

with the Securities and Exchange Commission. 

Confidential Treatment Requested 

Under 17 C.F.R. Sections 200.80(b)(4) 

and 240.24b-2. 

DATED THIS 24 DAY OF JAN 2017 

Between 
 NANYANG TECHNOLOGICAL
UNIVERSITY 
 And 
 ASLAN
PHARMACEUTICALS PTE LTD 
  
  

 
 AMENDMENT NO.1 TO 

LICENSING AND RESEARCH COLLABORATION AGREEMENT 
  

 
  

 THIS AMENDMENT AGREEMENT NO.1 (the “Amendment Agreement”) is made the 24 day of Jan, 2017 

BETWEEN 
  

	1.	NANYANG TECHNOLOGICAL UNIVERSITY (Reg. No. 200604393R), located at 50 Nanyang Avenue, Singapore 639798, and acting through its School of Biological Sciences (“NTU”), 

 

	    	and 

  

	2.	ASLAN PHARMACEUTICALS PTE LTD (Reg. No. 201007695N), a company incorporated in Singapore with a business address at UE Square (West Wing), 83 Clemenceau Avenue,
#12-03, Singapore 239920 (“Company”), 

 (hereinafter collectively
referred to as the “Parties” and individually as a “Party”). 
 WHEREAS: 

 

	(A)	The Parties have entered into a Licensing and Research Collaboration Agreement dated 10th October 2016 [NTU Ref: RCA-16/256]
(the “Principal Agreement”) for the project titled “Generation of domain antibodies for therapeutic applications”. 

  

	(B)	The Parties have agreed to amend the terms of the Principal Agreement in consideration of the mutual obligations and undertakings contained herein. 

THEREFORE the Parties do hereby agree as follows: 
  

	1.	INTERPRETATION 

  

	1.1	Unless otherwise provided in this Amendment Agreement, terms used in this Amendment Agreement shall have the same meaning and construction where defined in the Principal Agreement. 

 

	2.	AMENDMENTS TO THE PRINCIPAL AGREEMENT 

  

	2.1	The Parties hereby agree to amend the Principal Agreement, and any amendments to the Principal Agreement, pursuant to Clause 20.2 of the Principal Agreement, as follows: 

 

	 	(a)	By replacing Schedule 1 of the Principal Agreement in its entirety with the Schedule 1 attached to this Amendment Agreement. 

  

	2.2	Save as expressly provided or varied herein, all other terms and conditions of the Principal Agreement, and all rights and liabilities accruing before this Amendment Agreement comes into effect shall remain unaffected.

  

	2.3	This Amendment Agreement shall be effective as of 15th December 2016. 

  

	2.4	This Amendment Agreement shall be read and take effect as one with the Principal Agreement. 

  

			
		  	Page 2 of 28

	3.	GOVERNING LAW 

  

	3.1	This Amendment Agreement shall be governed by, interpreted and construed in accordance with the laws of Singapore. 

IN WITNESS WHEREOF the Parties have caused this Agreement to be executed on the date first above written. 

 

			
	 SIGNED by for and on behalf of
	  	SIGNED by for and on behalf of
		
	 NANYANG TECHNOLOGICAL UNIVERSITY
	  	ASLAN PHARMACEUTICALS PTE LTD
		
	 /s/ Zoynek
Bozdech                
	  	/s/ Carl Firth                        
	 Name: Prof. Zoynek Bozdech
	  	Name:     Carl Firth
		
	 Designation: Associate Chair (Research)

School of Biological Sciences

Nanyang Technological University
	  	 Designation:     CEO

		
	 In the presence of:
	  	In the presence of:
		
	 /s/ Pär
Nordlund                    
	  	/s/ Joanne Koh                    
	 Name: Pär Nordlund
	  	Name:     Joanne Koh
		
	 Designation: Professor, group leader
	  	Designation: Executive Assistance

  

			
	***Confidential Treatment Requested	  	Page 3 of 28

 SCHEDULE 1 

RESEARCH PROJECT 
 Title
:Generation of domain antibodies for therapeutic applications 
  

	1.	BACKGROUND/ INTRODUCTION/ OBJECTIVES AND SCOPE OF THE WORK 

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 4 of 28

	2.	DELIVERABLES 

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 5 of 28

	3.	CONTRIBUTIONS TO THE RESEARCH PROJECT/ BUDGET 

  

	 	(a)	In-kind Contribution by NTU to the Research Project 

  

	 	    	[...***...] 

  

			
	***Confidential Treatment Requested	  	Page 6 of 28

							
	(b)	    	In-kind Contribution by the Company to carry out the Research Project	  	 	S$	 
		    	[...***...]	  			
		    		  	  
	  
	 
		    	Total:	  	 	37,000	 
		    		  	  
	  
	 
	(c)	    	Funding by the Company to NTU to complete the 3 research streams described in the research Project	  	 	S$	 
		    	[...***...]	  			
		    		  	  
	  
	 
		    	Total Amount Payable*	  	 	255,000	 
		    	[...***...]	  			

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 7 of 28

	4.	PAYMENT SCHEDULE 

 The Company shall pay the Total Amount Payable of S$255,000 [...***...] in
accordance with the following schedule of payment: 
  

											
		  		 	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  		  		  	
	 [...***...]
	  	 [...***...]
	 	[...***...]	  		  		  	
	 [...***...]
	  		 		  		  		  	
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  	 [...***...]
	 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  		 		  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  		 	[...***...]	  	[...***...]	  	[...***...]	  	[...***...]
	 [...***...]
	  		 		  	[...***...]	  		  	
	 [...***...]
	  		 		  		  	[...***...]	  	
	 Total for Stream 1, 2 and 3
	  		 		  		  		  	255,000

 [...***...] 
  

	5.	BACKGROUND IP 

 [...***...] 

  

			
	***Confidential Treatment Requested	  	Page 8 of 28

 DATED THIS 26th DAY OF October 2017 

Between 
 NANYANG TECHNOLOGICAL
UNIVERSITY 
 And 

ASLAN PHARMACEUTICALS PTE LTD 
  

 
  

AMENDMENT NO.2 TO 

LICENSING AND RESEARCH COLLABORATION AGREEMENT 
  

 
  

 CONFIDENTIAL 

THIS AMENDMENT AGREEMENT NO .2 (the “Amendment Agreement No. 2”) is made the 26th day of October 2017 

BETWEEN 
  

	1.	NANYANG TECHNOLOGICAL UNIVERSITY (Reg. No. 200604393R), located at 50 Nanyang Avenue, Singapore 639798, and acting through its School of Biological Sciences (“NTU”), 

and 
  

	2.	ASLAN PHARMACEUTICALS PTE LTD (Reg. No. 201007695N), a company incorporated in Singapore with a business address at UE Square (West Wing), 83 Clemenceau Avenue,
#12-03, Singapore 239920 (“Company”), 

 (hereinafter collectively
referred to as the “Parties” and individually as a” Party”). 
 WHEREAS: 

 

	(A)	The Parties have entered into a Licensing and Research Collaboration Agreement dated 10th October 2016 [NTU Ref: RCA-16/256]
(the “Principal Agreement”) for the project titled “Generation of domain antibodies for therapeutic applications”. 

  

	(B)	The Principal Agreement was amended by the parties on 24th January 2017. 

  

	(C)	The Principal Agreement currently states that, unless extended by mutual agreement of the Parties, it will lapse on 10th October 2017. 

 

	(D)	The Parties wish to extend the term of the Principal Agreement as set out below. 

 THEREFORE the Parties
do hereby agree as follows: 
  

	1.	INTERPRETATION 

  

	1.1	Unless otherwise provided in this Amendment Agreement No. 2, terms used in this Amendment Agreement No. 2 shall have the same meaning and construction where defined in the Principal Agreement.

  

	2.	AMENDMENTS TO THE PRINCIPAL AGREEMENT 

  

	2.1	The Parties hereby agree to amend the Principal Agreement, and any amendments to the Principal Agreement, by replacing Clause 3.1 of the Principal Agreement in its entirety with the following: 

This Agreement shall come into force on the Effective Date and shall continue for a period of eighteen months (the “Term”)
unless terminated earlier in accordance with the terms of this Agreement. Notwithstanding the foregoing, this Agreement may be extended by mutual written agreement of the Parties. 

  

			
		  	Page 2 of 3

 CONFIDENTIAL 
  

	2.2	Save as expressly provided or varied herein, all other terms and conditions of the Principal Agreement, and all rights and liabilities accruing before this Amendment Agreement No. 2 comes into effect shall remain
unaffected. 

  

	2.3	This Amendment Agreement No. 2 shall be effective as of 10th October 2017. 

 

	2.4	This Amendment Agreement No. 2 shall be read and take effect as one with the Principal Agreement. 

  

	3.	GOVERNING LAW 

  

	3.1	This Amendment Agreement No. 2 shall be governed by, interpreted and construed in accordance with the laws of Singapore. 

IN WITNESS WHEREOF the Parties have caused this Amendment Agreement No. 2 to be executed on the date first above written. 

 

									
	SIGNED by for and on behalf of	  		  	SIGNED by for and on behalf of
			
	NANYANG TECHNOLOGICAL UNIVERSITY	  		  	ASLAN PHARMACEUTICALS PTE LTD
			
	 /s/ Peter Preiser
	  		  	 /s/ Ben Goodger

	Name: Prof Peter Preiser	  		  	Name: Ben Goodger
					
	Designation:	 	 Chair
	  		  	Designation:	  	 General Counsel

	 School of Biological Sciences
	  		  		  	
			
	In the presence of:	  		  	In the presence of:
			
	 /s/ Pär Nordlund
	  		  	 /s/ Nishi Singh

	Name: Pär Nordlund	  		  	Name: Nishi Singh
					
	Designation:	 	 Chair
	  		  	Designation:	  	Legal Manager
	 School of Biological Sciences
	  		  		  	

  

			
		  	Page 3 of 3EX-10.8

 Exhibit 10.8 
  

 
 Original 

Certificate of Stamp Duty 
  

			
	Stamp Certificate Reference	  	:    213013-01LA3-1-343962116
	Stamp Certificate Issued Date	  	:    20/07/2016
		
	Applicant’s Reference	  	:    SES.NSA.KW00800.0159
	Document Reference Number	  	:    2016062801095 ver. 1.0
	Document Description	  	:    Acceptance to Offer of Lease (Ad valorem)
	Date of Document	  	:    15/07/2016
	 	  	 
		
	Property	  	:    83 CLEMENCEAU AVENUE, #12-03, SINGAPORE 239920
		
	Lessor/ Landlord	  	:    UNITED ENGINEERS LIMITED (UEN-LOCALCO -191200018G)
		
	 Lessee/ Tenant
	  	 :    ASLAN PHARMACEUTICALS PTE. LTD.
(UEN-LOCALCO - 201007695N)

		
	Stamp Duty	  	:    S$ 4,536.00
	Total Amount	  	:    S$ 4,536.00

 To confirm if this Stamp Certificate is genuine, you may do an online check at https:llestamping.iras.gov.sg. Under Stamp
Duty Resource, select Verify Stamp Certificate Authenticity. 
  
  

 

			
	KP2L514L - 20/07/2016	  	213013-01LA3-1-343962116
	2016062801095	  	
	1a6a69f37d8a0f6b641102921231704f	  	
		  	Page 1 of 1

 

 
 Ref: OFF/LOO/#12-03/ASLAN//GC 

 

	 16 June 2016 
	
BY COURIER                   
                          

ASLAN PHARMACEUTICALS PTE.LTD. 
 10A Bukit Pasoh Road 

Singapore 089824 
 Attention :    Mr Carl
Aslan Jason Morton Firth 

                      Chief Executive Officer

 Dear Sirs, 
 LETTER OF OFFER FOR 83 CLEMENCEAU
AVENUE #12-03 UE SQUARE SINGAPORE 239920 
 United Engineers Limited (the “Landlord”) is
pleased to offer to you, M/s Aslan Pharmaceuticals Pte.Ltd. (the “Tenant”), a tenancy (the “Tenancy”) of the above unit on the following principal terms and conditions:- 

 

	1.	Premises 

  

	    	#12-03, 83 Clemenceau Ave 

  

	2.	Floor Area 

  

	    	4,500.00 square feet approximately 

 A copy of the floor plan edged red is attached (for
identification purposes only). The floor area shall be subject to final site measurement and relevant authority’s approval. 
  

	3.	Lease Term 

  

	    	Three (03) years 

  

	4.	Term of Tenancy 

  

	    	1 October 2016—30 September 2019 (both dates inclusive) 

  

	5.	Option to Renew 

  

	    	Further option to renew for 3 years at the then prevailing market rent. 

  

					
	6.	  	Rent and Service Charge	  	
			
		  	Rent @ S$5.95 psf per month	  	S$26,775.00 per month
		  	Service Charge @ S$1.05 psf per month	  	S$  4,725.00 per month
		  	Total Monthly Gross Rent @S$7.00 psf per month	  	S$31,500.00 per month

  

					
	12 Ang Mo Kio Street 64	  		  	
	#034A-01 UE Bix Hub CENTRAL	  	T : (65) 6818 8383	  	United Engineers Limited
	Singapore 569088	  	F : (65) 6818 8398	  	www.uel.com.sg

 Page 2 

UE SQUARE OFFICE: LETTER OF OFFER FOR #12-03 

 
  

  

	 	•	 	Rent and Service Charge shall be payable monthly in advance from date of commencement of the Term of the Tenancy. 

  

	 	•	 	The above Service Charge rate is a current estimation and is subject to change from time to time. 

  

	 	•	 	In the event that after acceptance of this offer, the Tenant fails to observe or perform (or threatens to commit a breach of or not to perform) the Tenant obligations under this letter, or to take possession of the
Demised Premises in accordance with the terms and conditions of this Letter of Offer, or bankruptcy/winding-up proceedings are commenced against the Tenant, then without prejudice to any other rights or
remedies available to the Landlord, at law or in equity, the Landlord may terminate this agreement by written notice to the Tenant, whereupon the Landlord shall have the absolute right to forfeit the security deposit. 

 

	7.	Taking Possession 

 The Tenant shall take possession of the Premises on
1 September 2016 in its bare and original condition subject to the Tenant having paid to the Landlord prior to the taking possession (i) 3 months’ Security Deposit; (ii) 1 month’s advance Gross Rent;
(iii) the Fitting-Out Deposit of $3,000.00; and (iv) the Landlord’s legal fees, stamp duty and disbursements. 

Any delay in the Tenant taking possession of the Premises shall not be a ground for postponing the rental commencement date. 

 

	8.	Goods and Services Tax 

 All goods and services tax in relation to the Rent, Service
Charge and other sums payable by the Tenant under this Letter of Renewal shall be paid by the Tenant. 
  

	9.	Security Deposit 

  

	 	(a)	The Tenant shall deposit an amount of S$94,500.00 equivalent to three (03) months’ Rent and Service Charge by way of Cash or Banker’s Guarantee to the Landlord upon acceptance of
this letter of offer. Such deposit shall be refunded to the Tenant, free of interest, on the expiration of the lease term, subject to the due performance and observance by the Tenant of all the principal covenants, conditions stipulated in the
Tenancy Agreement. 

  

	 	(b)	In the event that after acceptance of this offer, 

  

	 	(i)	the Tenant fails to observe or perform (or threatens to commit a breach of or not to perform) the Tenant obligations under this letter; or 

 

	 	(ii)	the Tenant fails to execute the Tenancy Agreement within two (02) weeks of receipt of the same; or 

  

	 	(iii)	bankruptcy/winding-up proceedings are commenced against the Tenant, then without prejudice to any other rights or remedies available to the Landlord, at law or in equity, the
Landlord may terminate this agreement by written notice to the Tenant, whereupon the Landlord shall have the absolute right to forfeit the entire security deposit. 

 Page 3 

UE SQUARE OFFICE: LETTER OF OFFER FOR #12-03 

 
  

	10.	Permitted Use 

 The Premises shall only be used as an office. 

 

	11.	Fitting-Out Period / Rent-free Period 

 The
Landlord shall grant to the Tenant a Fitting-Out Period (free of Rent and Service Charge) of One month commencing 1 September 2016 till 30 September 2016
(both dates inclusive) for the Tenant to carry out the Tenant’s Works. 
 In the event that the Term of the Tenancy is
prematurely terminated by the Tenant for any reason whatsoever or the same is determined by the Landlord in consequence of the Tenant’s breach of the terms and conditions applicable thereto, the Tenant shall compensate and pay to the Landlord
on demand an amount calculated at the monthly rate equivalent to the Rent and Service Charge which would have been applicable if the Fitting out period constituted part of the term of the Lease; and for the entire duration of the Rent -free
Period. 
  

	12.	Tenant’s Works 

 Subject to the prior written approval of the Landlord and to all
approvals being obtained by the Tenant from the relevant authorities the Tenant may in accordance with the provisions of the Tenancy Agreement carry out within the Premises at the Tenant’s own cost and expense all fitting out works which are
not provided by the Landlord. 
 The Tenant shall comply with the guidelines, terms and conditions set out in the Tenant’s Fitting-Out Brief). 
  

	13.	Utilities 

 The Tenant shall at its own cost and expense arrange for the installation and
testing of the meter and any equipment or appliances required to separately measure the services supplied to the Demised Premises and for licensed electrical contractors to make the necessary applications to Landlord’s Designated Supplier. All
charges in respect of the supply of electricity and any other services supplied to the Premises and any taxes thereon shall be paid by the Tenant. 
  

	14.	Car Parks 

 The Landlord will allocate to the Tenant two (02) season car parking
lots at prevailing parking charges, payable in advance. 
  

	15.	Reinstatement 

 Upon the expiration or sooner determination of the Term of the Tenancy,
the Tenant shall reinstate the Premises to a bare original condition. 
  

	16.	Air-conditioning Hours 

 The Landlord will
provide air-conditioning to the Demised Premises daily from 8:00am to 6:00pm on Mondays through Fridays, and from 8:00 am to 1:30pm on Saturdays, save for Sundays and gazetted public holidays or during such
other times as the parties may mutually agree to in writing, provided always that the Tenant bear the payment for extension of any air-conditioning hours at the prevailing charges. 

 Page 4 

UE SQUARE OFFICE: LETTER OF OFFER FOR #12-03 

 
  

	17.	Rent free Period 

 The Landlord shall grant to the Tenant a Rent Free Period (free of
Gross Rent) of 0.5 month for the period from 15 September 2019 to 30 September 2019. 
 In the event the Tenancy is prematurely
terminated by the Tenant for any reason whatsoever or the same is determined by the Landlord in consequences of the Tenant’s breach of the terms and conditions applicable hereto, the Tenant shall compensate and pay to the Landlord on demand an
amount calculated at the monthly rate equivalent to the Rent and Service Charge which could have been applicable if the rent free period constituted part of the Term of the tenancy; and for the entire duration of the Rent Free Period. This right is
only enforceable in the event of non performance under the Tenancy Agreement whereby the Landlord is, per the Tenancy Agreement, permitted to terminate the Tenancy. 
  

	18.	Documentation 

 Tenant’s acceptance of this offer is deemed acceptance of the terms
in the Tenancy Agreement. A specimen copy of the Tenancy Agreement has been forwarded to the Tenant. The Tenant shall execute the Tenancy Agreement within two (2) weeks upon receipt of the document. 

The Tenant shall upon the Tenant’s execution of the Tenancy Agreement, furnish to the Landlord: 

 

	 	•	 	a certified true copy of the Tenant’s Memorandum and Articles of Association certified by a director or company secretary of the Tenant; and 

 

	 	•	 	a certified extract of the Tenant’s director’s resolutions approving the entry into the Tenancy and authorising a signatory to execute the Tenancy Agreement for and on the Tenant’s behalf, certified by a
director or company secretary of the Tenant. 

  

	19.	Terms and Conditions of Tenancy 

 The Tenancy shall be subject to and in accordance with
all conditions, covenants, terms and provisions contained in the specimen Tenancy Agreement, as modified by the specific terms set out in this letter and in the Tenant’s Fitting-Out Brief (collectively
referred to as the ‘Documents’) . 
 Until the execution of the Tenancy Agreement: - 

 

	 	•	 	the provisions contained in the Documents shall apply and be binding on the Tenant and the Landlord as though such provisions had been incorporated in this letter; 

 

	 	•	 	the Tenant and the Landlord shall be liable to observe and perform the same obligations as are imposed by the covenants on the part of the Tenant and on the part of the Landlord respectively and the conditions contained
in the Documents in so far as they are not inconsistent with the provisions of this offer; and 

  

	 	•	 	the Landlord shall have and be entitled to all remedies by distress, action or otherwise for recovering any monies or for breach of any obligation on the part of the Tenant as if the Tenancy Agreement had then been
executed. 

 Page 5 

UE SQUARE OFFICE: LETTER OF OFFER FOR #12-03 

 
  

	20.	Legal Fees and Stamp Duty 

 The Landlord’s legal fees and expenses in connection
with the preparation of the above documentation, including stamp duty thereon shall be borne by the Tenant. 
  

	21.	Non-merger Clause 

 The provisions of this letter
shall remain in full force and effect after the execution of the Tenancy Agreement, in so far as they are still required to be observed and performed and are not provided for in the Tenancy Agreement. 

 

	22.	Definitions 

 Expressions which are not expressly defined herein shall have the same
meanings ascribed to them in the attached form of the specimen Tenancy Agreement. 
  

	23.	Contracts (Rights of Third Parties) Act, Chapter 53B 

 A person who is not a party to
this Letter of Offer has no right under the Contracts (Rights of Third Parties) Act, Chapter 53B to enforce any term of this letter. 
  

	24.	Confidentiality 

 The Tenant shall keep confidential and shall not at any time disclose
or permit to be disclosed any terms, conditions and/or provisions of the Tenancy Agreement, or any negotiations or discussions or agreement for a renewal of the Tenancy or any matter in relation to the Tenancy Agreement, except with the prior
written consent of the Landlord or as required by law or to the extent that such information has become public knowledge not due to the Tenant’s breach of this undertaking. 

All terms and references used in this Letter of Offer which are defined or construed in the Tenancy Agreement, but are not defined or construed in this Letter
of Offer, shall have the same meaning and construction in this Letter of Offer. 
 Save as specifically provided herein, the terms and conditions under the
Tenancy Agreement are deemed incorporated in this Letter of Offer. Further, the terms and conditions under the Tenancy Agreement shall not be affected by nor shall our respective rights and liabilities thereunder be discharged, diminished or
nullified in any way whatsoever by the contents of this Letter of Offer. If there is any inconsistency between the terms and conditions under the Tenancy Agreement and this Letter of Offer, the contents of this Letter of Offer shall prevail. 

 Page 6 

UE SQUARE OFFICE: LETTER OF OFFER FOR #12-03 

 
  

 To accept this offer, please proceed with the following: - 

 

	(a)	signify your acceptance by signing and returning to us the duplicate copy of this letter; 

  

	(b)	enclose a cheque or Banker’s Guarantee of S$94,500.00 being the 3 months’ Security Deposit, issued in favour of “UNITED ENGINEERS LIMITED”; 

 

	(c)	enclose a cheque of S$33,705.00 being 1 month’s advance Gross Rent (inclusive of GST), issued in favour of “UNITED ENGINEERS LIMITED”; 

 

	(d)	enclose a cheque of S$4,536.00 being the stamp duty payable for this document, issued in favour of “COMMISSIONER OF STAMP DUTIES”; and 

 

	(e)	enclose a cheque of S$3,376.39 being the legal fee payable payable for this document, issued in favour of “KHATTARWONG LLP”. 

Please note that post-dated cheques are not accepted. 
 This
offer shall lapse if not accepted within 7 calendar days from the date of this Letter of Offer. 
 Yours faithfully, 

UNITED ENGINEERS LIMITED 
 /s/ Quek Jing Yi 

MS QUEK JING YI 
 HEAD, CORPORATE LEASING 

 Page 7 

UE SQUARE OFFICE: LETTER OF OFFER FOR #12-03 

 
  

 ACCEPTANCE 
  

 
 I/We, Aslan Pharmaceuticals Pte.Ltd.
(“the Tenant”), hereby confirm our acceptance of the above principal terms and conditions. Enclosed are (i) a cheque or Banker’s Guarantee of S$94,500.00 being the 3 months’ Security Deposit, (ii) a cheque
of S$33,705.00 being the 1 month’s advance rent (inclusive of GST); (iii) a cheque of S$4,536.00 being the stamp duty payable; and (iv)a cheque of S$3,376.39 being the legal fee payable. We agree that the Security Deposit
is non-refundable in the event we fail to execute the Tenancy Agreement within 14 days upon receipt of the same. 
  

 

			
	 /s/ Carl Aslan Jason Morton Eirth

Authorised Signatory / Company’s Stamp
 For and on behalf
of
 M/s Aslan Pharmaceuticals Pte.Ltd.
 Name:
Mr. Carl Aslan Jason Morton Eirth
 Designation: Chief Executive officer

Date:15 July 2016
	 	 

  
 

 

 

 

Dated                       
              

            25 July
2016             
 UNITED ENGINEERS LIMITED 

and 
 ASLAN PHARMACEUTICALS
PTE. LTD. 
  
  

TENANCY AGREEMENT 
 in
respect of Unit #12-03 
 83, Clemenceau Avenue 

UE SQUARE 
 SINGAPORE
239920 
  
  

KHATTARWONG LLP 

ADVOCATES & SOLICITORS 

SINGAPORE 
 Our Ref: SES nsa
KW00800.0159 

 TABLE OF CONTENTS 

 

							
	Contents	  	Page	 
	1.	 	 INTERPRETATION
	  	 	1	 
	1.1	 	 Definitions
	  	 	1	 
	1.2	 	 Interpretation of restrictions on the Tenant
	  	 	3	 
	1.3	 	 Schedules and Annexures
	  	 	3	 
	1.4	 	 Clause and paragraph headings
	  	 	3	 
	1.5	 	 Singular and plural meanings
	  	 	3	 
	1.6	 	 Statutes and statutory instruments
	  	 	3	 
	1.7	 	 Gender
	  	 	3	 
	1.8	 	 Joint and several obligations
	  	 	3	 
	2.	 	 THE DEMISE, POSSESSION AND FITTING-OUT

	  	 	4	 
	2.1	 	 The Demise
	  	 	4	 
	2.2	 	 Possession
	  	 	4	 
	2.3	 	 Fitting Out Period
	  	 	4	 
	2.4	 	 Tenant’s Works
	  	 	4	 
	3.	 	 TENANT’S COVENANTS
	  	 	5	 
	3.1	 	 Rent, Service Charge, Interest and Taxes
	  	 	5	 
	3.2	 	 Utilities
	  	 	5	 
	3.3	 	 Security Deposit
	  	 	5	 
	3.4	 	 Insurance
	  	 	5	 
	3.5	 	 Repair
	  	 	6	 
	3.6	 	 Alterations
	  	 	6	 
	3.7	 	 Landlord’s right of inspection and right of
repair
	  	 	6	 
	3.8	 	 Landlord’s right of entry for repairs etc
	  	 	6	 
	3.9	 	 Yield up in repair at the end of the Term
	  	 	6	 
	3.10	 	 User
	  	 	6	 
	3.11	 	 Covenants affecting use of Demised Premises and
Building
	  	 	7	 
	3.12	 	 Advertisements and signs
	  	 	7	 
	3.13	 	 Car parks
	  	 	7	 
	3.14	 	 Compliance with statutes etc
	  	 	8	 
	3.15	 	 Notices ‘to let’
	  	 	8	 
	3.16	 	 Indemnity by Tenant
	  	 	8	 
	3.17	 	 Assignment and subletting
	  	 	9	 
	3.18	 	 No registration of tenancy
	  	 	9	 
	3.19	 	 Confidentiality
	  	 	10	 
	3.20	 	 Personal Data Protection
	  	 	10	 

  
 i 

							
	4.	 	 LANDLORD’S COVENANTS
	  	 	11	 
	4.1	 	 Quiet enjoyment
	  	 	11	 
	4.2	 	 Property tax
	  	 	11	 
	4.3	 	 Management of the Building
	  	 	11	 
	5.	 	 LANDLORD NOT LIABLE
	  	 	12	 
	5.1	 	 No claim by Tenant
	  	 	12	 
	5.2	 	 Transfer to Management Corporation
	  	 	13	 
	5.3	 	 Accidents
	  	 	13	 
	6.	 	 PROVISOS
	  	 	13	 
	6.1	 	 Proviso for
re-entry
	  	 	13	 
	6.2	 	 Power for Landlord to deal with adjoining property and the Demised Premises

	  	 	14	 
	6.3	 	 Removal of property after determination of Term
	  	 	15	 
	6.4	 	 Notices, consents and approvals
	  	 	15	 
	6.5	 	 Payments
	  	 	16	 
	6.6	 	 Determination of Floor Area
	  	 	16	 
	6.7	 	 Costs and expenses
	  	 	16	 
	6.8	 	 Untenantability
	  	 	16	 
	6.9	 	 No waiver
	  	 	17	 
	6.10	 	 No representations
	  	 	17	 
	6.11	 	 Name of UE Square
	  	 	17	 
	6.12	 	 Rules and regulations
	  	 	17	 
	6.13	 	 Holding over
	  	 	18	 
	6.14	 	 Changes to Plans
	  	 	18	 
	6.15	 	 Landlord’s right to assign
	  	 	18	 
	6.16	 	 Severance
	  	 	19	 
	6.17	 	 Governing law and submission to jurisdiction
	  	 	19	 
	6.18	 	 Provisions for Renewal
	  	 	19	 
	6.19	 	 Contracts (Rights of Third Parties) Act (Cap 53B)
	  	 	19	 
	 Appendix A
	  	 	20	 
	 Schedule 1
	  	 	22	 
	 Schedule 2
	  	 	23	 
	 Schedule 3
	  	 	24	 
	 Schedule 4
	  	 	27	 
	 Schedule 5
	  	 	28	 
	 Schedule 6
	  	 	32	 
	 Schedule 7
	  	 	35	 
	 Schedule 8
	  	 	37	 

  
 ii 

							
	 Schedule 9
	  	 	38	 
	 Schedule 10
	  	 	39	 
	 Schedule 11
	  	 	40	 
	 Schedule 12
	  	 	42	 
	 Schedule 13
	  	 	43	 
	 Schedule 14
	  	 	45	 
	 Schedule 15
	  	 	47	 
	 Schedule 16
	  	 	50	 
	 Annexure A
	  	 	51	 

  
 iii 

 This Agreement is made on
                     between: 
  

	(1)	UNITED ENGINEERS LIMITED, a company incorporated in Singapore and having its registered office at 12 Ang Mo Kio Street 64 #01-01 UE BizHub CENTRAL Singapore 569088 (the
“Landlord” ); and 

  

	(2)	the party named in paragraph 1 of Appendix A (the “Tenant”). 

 NOW THIS TENANCY
AGREEMENT WITNESSETH as follows: 
  

	1.	INTERPRETATION 

  

	1.1	Definitions 

 In this Tenancy Agreement the following words and expressions shall where
the context so admits have the following meanings: 
 “Bare and Original Condition” means the state and condition of the
Demised Premises as at the Possession Date (hereinafter defined). 
 “Building” means all that portion of UE Square
comprising the integrated office and retail premises known as 83 Clemenceau Avenue (of which the Demised Premises forms part). 

“Common Property” means all the parts of UE Square as are not comprised in any strata lot shown on the strata title plan
lodged with the Registrar of Titles in respect of UE Square and includes all apparatus and installations and other areas within the definition of common property as defined in the Land Titles (Strata) Act (Cap 158). 

“Conducting Media” means drains, sewers, conduits flues, gutters, gullies, channels, ducts, shafts, watercourses, pipes,
cables, wires and mains or any of them. 
 “Demised Premises” means the premises described in paragraph 2 of Appendix
A; the boundaries and location of which are edged in red in the attached plan(s) marked Annexure A, excluding the exterior faces of external walls, the exterior faces of boundary walls and the roof. 

“Fitting Out Deposit” means the sum deposited by the Tenant with the Landlord pursuant to Clause 2.4.2 and specified in
paragraph 6 of Appendix A. 
 “Fitting Out Period” means the period referred to in Clause 2.3.1 and specified in
paragraph 5(b) of Appendix A. 
 “Floor Area” means the area of the floor of the Demised Premises measured to include
(i) half the thickness of the walls/partitions/glass (as the case may be) which form the external boundary of the Demised Premises and (ii) the area occupied by all pillars, columns, mullions, internal partitions and projections within the
Demised Premises and shall be accepted by the parties as the area specified in paragraph 3 of Appendix A. 

“Interest” means interest at the rate as determined by the Landlord to be 4% above the prime lending rate of Oversea-Chinese
Banking Corporation Limited prevailing from time to time, calculated on a daily basis and on the basis of a three hundred and sixty-five (365) days year (as well after as before judgment). 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -1- 

 “Landlord” includes its successors, assigns and all persons entitled to the
reversion immediately expectant upon the determination of this tenancy. 
 “Management Corporation” means the management
corporation established for UE Square under the Land Titles (Strata) Act (Cap 158). 
 “Payment Date” means the date(s) as
defined in paragraph 1.1 of Schedule 4. 
 “permitted occupier” means any person on the Demised Premises expressly or
by implication with the Tenant’s authority. 
 “person” includes any individual, company, corporation, firm,
partnership, joint venture, association, organisation, trust, state or agency of a state (in each case, whether or not having separate legal personality). 

“Possession Date” means the date referred to in Clause 2.2.1 and specified in paragraph 5(a) of Appendix A. 

“Project Consultants” means the architect, mechanical and electrical engineer, structural engineer and other professional
consultants engaged by the Landlord for UE Square. 
 “Rent” means the rent payable by the Tenant in accordance with
Schedule 4. 
 “Requisite Consents” means those permissions, consents, approvals, licences, certificates and permits
in legally effectual form as may be necessary to lawfully commence, carry out and complete the Tenant’s Works. 
 “Security
Deposit” means the sum deposited by the Tenant with the Landlord pursuant to Clause 3.3 and specified in paragraph 7 of Appendix A. 

“Service Charge” means the charges payable by the Tenant to the Landlord in accordance with Schedule 5. 

“Tenancy Agreement” includes any instruments supplemental to it. 

“Tenant” includes, if the Tenant is an individual, his personal representatives and permitted assigns, or if the Tenant is a
company, its successors in title. 
 “Tenant’s Fitting Out Brief” means the printed guidelines prepared by the Landlord
and furnished to the Tenant, including any amendments or modifications thereto from time to time. 
 “Tenant’s Works”
means such fitting out or other works as the Tenant may require to carry out in connection with the use and enjoyment of the Demised Premises as office premises. 

“Term” means the tenancy term granted by this Tenancy Agreement and specified in paragraph 4 of Appendix A. 

“UE Square” means the complex known or to be known as UE SQUARE, or such other name as may be decided by the Landlord in its
absolute discretion with the approval of the relevant authority comprising office commercial and residential premises erected on Government Resurvey Lots 109 and 172, all Town Subdivision 9 and bounded by Clemenceau Avenue, River Valley Road and
Mohammed Sultan Road, of which the Demised Premises forms part and refers to each and every part of UE Square and the car parks, service, loading and any other areas the use and enjoyment of which is appurtenant to UE Square. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -2- 

	1.2	Interpretation of restrictions on the Tenant 

 In any case where the Tenant is placed
under a restriction by reason of the covenants and conditions contained in this Tenancy Agreement, the restriction shall be deemed to include the obligation on the Tenant not to permit or allow the infringement of the restriction by any person
claiming rights to use, enjoy or visit the Demised Premises through, under or in trust for the Tenant. 
  

	1.3	Schedules and Annexures 

 The Schedules and Annexures hereto shall be taken, read and
construed as parts of this Tenancy Agreement and the provisions thereof shall have the same force and effect as if expressly set out in the body of this Tenancy Agreement. 
  

	1.4	Clause and paragraph headings 

  

	 	1.4.1	The clause and paragraph headings in this Tenancy Agreement are for ease of reference only and shall not be taken into account in the construction or interpretation of any covenant, condition or proviso to which they
refer. 

  

	 	1.4.2	References in this Tenancy Agreement to a clause, Appendix, Schedule or Annexure are references where the context so admits to a clause, Appendix, Schedule or Annexure in this Tenancy Agreement. References in a clause
to a paragraph are (unless the context otherwise requires) references to a paragraph of that clause, and references in a Schedule to a paragraph are (unless the context otherwise requires) references to a paragraph of that Schedule.

  

	1.5	Singular and plural meanings 

 Words in this Tenancy Agreement importing the singular
meaning shall where the context so admits include the plural meaning and vice versa. 
  

	1.6	Statutes and statutory instruments 

 References in this Tenancy Agreement to any statutes
or statutory instruments shall include and refer to any statute or statutory instrument amending, consolidating or replacing them respectively from time to time and for the time being in force. 

 

	1.7	Gender 

 Words in this Tenancy Agreement for the masculine gender shall include the
feminine and neuter genders and vice versa and words denoting natural persons shall include corporations and firms and all such words shall be construed interchangeably in that manner. 

 

	1.8	Joint and several obligations 

 Where two or more persons are included in the term
“Tenant” all covenants, agreements, terms, conditions and restrictions shall be binding on and applicable to them jointly and each of them severally, and shall also be binding on and applicable to their personal representatives and
permitted assigns respectively jointly and severally. 
  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -3- 

	2.	THE DEMISE, POSSESSION AND FITTING-OUT 

  

	2.1	The Demise 

  

	 	2.1.1	In consideration of the Rent, Service Charge and the covenants reserved by and contained in this Tenancy Agreement, the Landlord HEREBY LETS to the Tenant ALL the Demised Premises TOGETHER WITH the rights set out in
Schedule 1 but EXCEPTING AND RESERVING to the Landlord the rights as stated in Schedule 2, TO HOLD the Demised Premises unto the Tenant for the Term specified in paragraph 4 of Appendix A, the Tenant paying to the Landlord
during the Term the Rent in accordance with the provisions in Schedule 4 and the Service Charge in accordance with the provisions in Schedule 5. 

  

	2.2	Possession 

  

	 	2.2.1	The Landlord shall give and the Tenant shall take possession of the Demised Premises on the date specified in paragraph 5(a) of Appendix A (the “Possession Date” ), subject to the Tenant having
paid to the Landlord prior to the taking of possession, the following sums: (i) the Security Deposit, (ii) the Fitting Out Deposit, (iii) one (1) month’s Rent and Service Charge in advance, (iv) the Landlord’s legal
fees in connection with the preparation and completion of this Tenancy Agreement and all stamp duty and all other disbursements and out-of- pocket expenses in respect thereof. 

 

	 	2.2.2	Any delay in the Tenant taking possession of the Demised Premises shall not be a ground for postponing the commencement of the Fitting Out Period. 

 

	2.3	Fitting Out Period 

  

	 	2.3.1	The Landlord agrees to grant the Tenant a fitting out period (free of Rent and Service Charge) for the duration specified in paragraph 5(b) of Appendix A (the “Fitting Out Period” ) commencing
from the Possession Date, for the Tenant to carry out the Tenant’s Work which shall be completed by the Tenant within the Fitting Out Period. 

  

	 	2.3.2	In the event that the Term of the tenancy is prematurely terminated by the Tenant for any reason whatsoever or the same is determined by the Landlord in consequence of the Tenant’s breach of the terms and
conditions applicable thereto, then without prejudice to any other rights and remedies of the Landlord, the Tenant shall compensate and pay to the Landlord, on demand, an amount for the entire duration of the Fitting Out Period equivalent to the
Rent and Service Charge which would have been payable if the Fitting Out Period constituted part of the Term of the tenancy. 

  

	2.4	Tenant’s Works 

  

	 	2.4.1	Subject always to and in accordance with the provisions set out in Schedule 3, the Tenant shall carry out at the Tenant’s own costs and expense all works required by the Tenant for purpose of fitting out the
Demised Premises and shall comply with and observe the guidelines, terms and conditions set out in the Tenant’s Fitting Out Brief. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -4- 

	 	2.4.2	The Tenant shall deposit with the Landlord the sum specified in paragraph 6 of Appendix A (the “Fitting Out Deposit”) at the time and in the manner and in accordance with the provisions set out
in paragraph 6 in Schedule 3. 

  

	3.	TENANT’S COVENANTS 

 The Tenant covenants with the Landlord as follows: 

 

	3.1	Rent, Service Charge, Interest and Taxes 

  

	 	3.1.1	To pay the Rent at the times and in the manner specified in Schedule 4 and the Service Charge at the times and in the manner specified in Schedule 5. 

 

	 	3.1.2	To pay such Interest as may become due on the Rent, Service Charge and other monies due under this Tenancy Agreement in accordance with the provisions set out in paragraph 1 in Schedule 6. 

 

	 	3.1.3	To pay any applicable goods and services tax, imposition, duty and levy whatsoever (hereinafter collectively called “Taxes”) which may be imposed on the Rent, Service Charge and other sums payable under
this Tenancy Agreement or to reimburse the Landlord for the payment of such Taxes in accordance with the provisions set out in paragraph 2 of Schedule 6. 

  

	 	3.1.4	To pay any increase in property tax attributable to the Demised Premises in accordance with the provisions set out in paragraph 3 of Schedule 6. 

 

	3.2	Utilities 

 To pay all charges including any taxes now or in the future imposed by the
supplier designated by the Landlord (“Designated Supplier”) or other appropriate authority in respect of electricity and/or chilled water supplied to all air-conditioning fan coil units and
any other services supplied and metered separately to the Demised Premises which shall be consumed or supplied on or to the Demised Premises, and to pay all necessary hire charges for any equipment or appliances supplied to the Tenant irrespective
of whether the same was installed by the Landlord or the Tenant and whether the electricity and/or chilled water is supplied during or beyond the operating hours of the Building and whether invoiced by a Designated Supplier, other supplier or by the
Landlord, and all transmission and transportation charges payable in connection with the supply of such electricity and/or chilled water supplied to all air-conditioning fan coil units and any other services
supplied to the Demised Premises in accordance with the provisions set out in Schedule 7. 
  

	3.3	Security Deposit 

 To deposit with the Landlord the sum specified in paragraph 7 of
Appendix A equivalent to three (3) months’ Rent and Service Charge for the Demised Premises (the “Security Deposit”) in accordance with the provisions set out in Schedule 8. 

 

	3.4	Insurance 

 To take out and keep in force a comprehensive public liability insurance
policy of an adequate amount in accordance with the provisions set out in Schedule 9. 
  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -5- 

	3.5	Repair 

 At all times to repair and to keep the Demised Premises in a clean and good
state of tenantable repair and condition (fair wear and tear excepted) in accordance with the provisions set out in Schedule 10. 
  

	3.6	Alterations 

 Not to make any alterations or additions to or affecting the structure or
exterior of the Demised Premises or the appearance of the Demised Premises as seen from the exterior except in accordance with the provisions set out in Schedule 11. 
  

	3.7	Landlord’s right of inspection and right of repair 

 Subject always to and in
accordance with the provisions set out in Schedule 12, to permit the Landlord and its servants or agents at all reasonable times and by prior appointment with the Tenant to enter into, inspect and view the Demised Premises and
examine their condition and also to take a schedule of fixtures in the Demised Premises. 
  

	3.8	Landlord’s right of entry for repairs etc 

  

	 	3.8.1	Subject always to and in accordance with the provisions set out in Schedule 13, to permit the Landlord and the agents, workmen and others employed by the Landlord or by the Management Corporation or by the other
tenants or occupiers of the Building to enter upon the Demised Premises for the purposes set out in Schedule 13. 

  

	 	3.8.2	To furnish to the Landlord the names, addresses and contact telephone numbers of at least two management staff (“Designated Employees”) who are in the employ of the Tenant and who would retain
possession of the keys to the Demised Premises on a twenty-four (24) hour basis, for the purposes and in accordance with the provisions of Schedule 13. 

 

	3.9	Yield up in repair at the end of the Term 

 At the expiration or earlier determination of
the Term to quietly yield up the Demised Premises in the Bare and Original Condition (fair wear and tear excepted) in accordance with the provisions set out in Schedule 14. 

 

	3.10	User 

  

	 	3.10.1	Not to use the Demised Premises otherwise than as office premises. 

  

	 	3.10.2	The Tenant shall not use or permit the use of the Demised Premises or any part thereof: 

  

	 	(i)	otherwise than for the purposes specified in Clause 3.10.1; 

  

	 	(ii)	for any purpose otherwise than in accordance with the permitted use approved by the relevant government authorities; and 

  

	 	(iii)	for the purposes specified in Clause 3.10.1, until and unless all necessary approvals, consents, licences and permits shall have been obtained from the relevant government authorities and such approvals, consents,
licences and permits remain valid and subsisting. 

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -6- 

	3.11	Covenants affecting use of Demised Premises and Building 

 The Tenant hereby covenants to
perform and observe at all times the covenants affecting the use of the Demised Premises and the Building set out in Schedule 15. 
  

	3.12	Advertisements and signs 

  

	 	3.12.1	Not without the Landlord’s prior written consent (which approval shall not be unreasonably withheld) to place or display on the exterior of the Demised Premises or on the windows or inside the Demised
Premises so as to be visible from the exterior of the Demised Premises any name, writing, notice, sign, illuminated sign, display of lights, placard, poster, sticker or advertisement other than: 

 

	 	(i)	the name of the Tenant signwritten on the entrance doors of the Demised Premises in a style and manner previously approved in writing by the Landlord; and 

 

	 	(ii)	the name of the Tenant displayed on the indicator board in the entrance lobby in the Building. 

  

	 	3.12.2	If any name, writing, notice, sign, placard, poster, sticker or advertisement shall be placed or displayed in breach of these provisions, to permit the Landlord to enter the Demised Premises and remove such name,
writing, notice, sign, placard, poster, sticker or advertisement and to pay to the Landlord on demand the expense of so doing. 

  

	3.13	Car parks 

  

	 	3.13.1	The Landlord may prohibit the Tenant and its officers and employees from parking in UE Square other than in designated parking areas and the Tenant shall at all times notify the Landlord of the vehicle registration
numbers of all vehicles currently owned or used by the Tenant, its officers and employees, such notification to be made initially within fourteen (14) days after the Tenant takes possession of the Demised Premises and thereafter within fourteen
(14) days after a change occurs. 

  

	 	3.13.2	The Tenant shall pay parking charges as may be levied or revised from time to time by the Landlord or the Management Corporation, for the use of car park lots in UE Square. 

 

	 	3.13.3	The Tenant, its officers and employees shall comply with all rules and regulations imposed from time to time by the Landlord or the Management Corporation for the management and operation of the car parks within UE
Square. 

  

	 	3.13.4	Subject to availability, the Landlord shall allocate to the Tenant two (2) season car park lots (not in specifically designated location) at prevailing charges payable monthly in advance for the use by the Tenant,
its officer and employees and the Landlord reserves the right to revise the allocation of number of carpark lots from time to time. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -7- 

	3.14	Compliance with statutes etc 

  

	 	3.14.1	Except where such liability may be expressly within the Landlord’s covenants contained in this Tenancy Agreement, to comply in all respects with the provisions of all statutes and regulations for the time being in
force and requirements of any competent authority relating to the Demised Premises or anything done in or upon the Demised Premises by the Tenant and to indemnify the Landlord against all actions, proceedings, claims or demands which may be brought
or made by reason of such statutes, regulations or requirements or any default in compliance with them. 

  

	 	3.14.2	In particular but without prejudice to the generality of Clause 3.14.1: 

  

	 	(i)	to comply with all requirements under any present or future Act of Parliament, order, by-law or regulation as to the use or occupation of or otherwise concerning the Demised
Premises; 

  

	 	(ii)	to execute with all due diligence all works to the Demised Premises for which the Tenant is liable in accordance with Clauses 3.14.1 and 3.14.2 and of which the Landlord has given notice to the Tenant; and

  

	 	(iii)	if the Tenant shall not comply with Clause 3.14.2(i) and (ii) to permit the Landlord to enter the Demised Premises to carry out such works and to pay to the Landlord on demand the expense of so doing (including
surveyors’ and other professional advisers’ fees) together with Interest from the date of expenditure until payment by the Tenant to the Landlord (such monies to be recoverable as if they were rent in arrears). 

 

	3.15	Notices ‘to let’ 

 Within six (6) months before the expiration or earlier
determination of the Term: 
  

	 	3.15.1	to permit the Landlord or its agents to fix upon the Demised Premises a notice board for reletting the Demised Premises; and 

  

	 	3.15.2	to permit all persons authorised by the Landlord or its agents to view without interruption the Demised Premises at reasonable hours and by prior appointment with the Tenant in connection with any such
reletting. 

  

	3.16	Indemnity by Tenant 

 To indemnify and keep indemnified the Landlord from and against:

  

	 	3.16.1	all claims, demands, writs, summonses, actions, suits, proceedings, judgements, orders, decrees, damages, costs, losses and expenses of any nature whatsoever which the Landlord may suffer or incur in connection with
loss of life, personal injury and/or damage to property arising from or out of any occurrences in, upon or at the Demised Premises or the use of the Demised Premises or any part thereof by the Tenant or by any of the Tenant’s employees,
independent contractors, agents or any permitted occupier; and 

  

	 	3.16.2	all loss and damage to the Demised Premises, the Building or UE Square and to all property therein caused directly or indirectly by the Tenant or the Tenant’s employees, independent contractors, agents or any
permitted occupier and in particular but without limiting the generality of the foregoing caused directly or indirectly by the use or misuse, waste or abuse of water, gas or electricity or faulty fittings or fixtures. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -8- 

	3.17	Assignment and subletting 

  

	 	3.17.1	Not to transfer, assign, sublet, mortgage or encumber this tenancy or the Demised Premises or any part thereof. 

  

	 	3.17.2	Not to licence, part with or share possession or occupation of the whole or any part of the Demised Premises or grant to third parties any rights over the Demised Premises. 

 

	 	3.17.3	For the purposes hereof where the Tenant is a company, any amalgamation and/or reconstruction effected by the Tenant or any change in the majority or controlling shareholders of the Tenant shall be deemed an assignment
of this tenancy. 

  

	 	3.17.4	In the event the Tenant makes a request to transfer, assign, sublet, mortgage or encumber this tenancy or the Demised Premises or any part thereof or to licence, part with or share possession or occupation of the whole
or any part of the Demised Premises or grant to third parties any rights over the Demised Premises, such request shall be accompanied by a sum of Dollard Five Hundred $500.00 in payment of the Landlord’s administrative costs in processing every
application made by the Tenant whether or not such consent or approval shall be granted or given. 

  

	 	3.17.5	The Landlord shall be entitled at its absolute discretion to impose such terms and conditions as it may think fit, as a condition of its consent, including but not limited to the requirement for the Tenant to pay to the
Landlord such amount or amounts as may be stipulated by the Landlord, whether such amount is calculated by reference to the difference between: 

  

	 	(i)	the amounts payable to the Tenant by its sub-tenant in respect of the premises proposed to be sublet; and 

 

	 	(ii)	the Rent and Service Charge payable to the Landlord by the Tenant apportioned to the premises proposed to be sublet, 

or otherwise, and payment of any legal costs and fees, stamp duty and all other disbursements and out-of-pocket expenses that may be incurred. The provisions of Section 17 of the Conveyancing And Law of Property Act (Cap 61) shall not apply to this Tenancy Agreement. 

 

	 	3.17.6	A consent granted by the Landlord shall not constitute a waiver of the requirement for the Landlord’s consent to any subsequent transfer, assignment, subletting, licensing, grant of possession, mortgage or
encumbrance of this tenancy or the Demised Premises or any part thereof. 

  

	3.18	No registration of tenancy 

 Not to register this tenancy at the Singapore Land
Authority, whether before or during the continuance of the Term. The Tenant shall not be entitled to require the Landlord to subdivide the Building or any part thereof or to do any act or thing which could result in the Landlord being required to
subdivide the Building or any part thereof. 
  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -9- 

	3.19	Confidentiality 

  

	 	3.19.1	The Tenant undertakes to the Landlord that it shall not (and shall procure its advisers, agents, officers and employees not to), without prior written consent of the Landlord, disclose to any person any of the terms or
conditions of this Tenancy Agreement at any time during or after the Term unless: 

  

	 	(i)	any such disclosure is required pursuant to (i) any applicable laws or any requirement of any competent governmental or statutory authority, or (ii) rules or regulations of any relevant regulatory, administrative
or supervisory body (including without limitation, any relevant stock exchange or securities council), or (iii) any legal process issued by any court or tribunal whether in Singapore or elsewhere; or 

 

	 	(ii)	the Tenant can reasonably demonstrate that information relating to such term or conditions of this Tenancy Agreement is, in whole or in part in the public domain, other than by reason of any wilful or negligent act or
omission of the Tenant, whereupon, to the extent that it is public, this obligation shall cease. 

  

	3.20	Personal Data Protection 

  

	 	3.20.1	Without prejudice to Clause 3.19, the Landlord or any of its authorised persons may at any time during the course of the Term collect, use and disclose, as the Landlord reasonably regards to be necessary, such
information or personal data about the Tenant to current or future related corporations of the Landlord or legal and financial institutions in connection with the purposes set out in the Landlord’s Data Protection Policy as of the date of this
Tenancy Agreement (available at: www.uel.com.sg/UELDPP.pdf) (“UEL DPP”) or in accordance with applicable law. 

  

	 	3.20.2	Where the information collected relates to personal data of the Tenant or any of its authorised representatives, the Tenant agrees, represents, warrants and undertakes that it has consented to the collection, use,
disclosure and/or processing of its personal data by the Landlord and the Landlord’s authorised persons in connection with the purposes set out in the UEL DPP or in accordance with applicable law. 

 

	 	3.20.3	The Landlord undertakes that it shall take all reasonable measures to ensure that any personal data of the Tenant which is held by the Landlord pursuant to this Tenancy Agreement is protected against loss, unauthorised
access, use, modification, disclosure or other misuse in accordance with the procedures set out in Schedule 1 of the Personal Data Protection Act 2012 (the “PDPA”), and that only authorised personnel will have access to the personal data.

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -10- 

	4.	LANDLORD’S COVENANTS 

 The Landlord covenants with the Tenant as follows: 

 

	4.1	Quiet enjoyment 

 That the Tenant paying the Rent and Service Charge and performing the
Tenant’s covenants reserved by and contained in this Tenancy Agreement may lawfully and peaceably hold and enjoy the Demised Premises throughout the Term without any interruption by the Landlord or by any person lawfully claiming through, under
or in trust for the Landlord. 
  

	4.2	Property tax 

 To pay the property tax levied or charged upon the Demised Premises
subject to the Tenant’s payment of its portion of the property tax as provided in Clause 3.1.4 of this Tenancy Agreement. 
  

	4.3	Management of the Building 

  

	 	4.3.1	Subject always to the provisions of Clauses 5.1 and 5.2 hereof and (in the event the Building is at anytime hereafter strata subdivided, then) until the management and operation of the Building is transferred to the
Management Corporation: 

  

	 	(i)	to keep the roof and the main drains and main pipes (which serve two or more units in the Building), all external walls and all common parts of the Building including entrances, car parks, staircases, pavements,
landings, corridors and passages, sewers, cables and lifts in good and tenantable condition and repair (fair wear and tear excepted); 

  

	 	(ii)	to provide: 

  

	 	(a)	air-conditioning services during the hours of 8.00 a.m. to 6.00 p.m. on weekdays and 8.00 a.m. to 1.30 p.m. on Saturdays (Sundays and public holidays excepted) Provided
Always that air-conditioning services may at the request of the Tenant be extended by the Landlord (but without any obligation so to do) beyond the hours hereinbefore defined and in such an event the Tenant shall bear and pay to the Landlord on
demand the prevailing charges charged by the Landlord for such extension; 

  

	 	(b)	lift services during the hours of 7.00 a.m. to 7.00 p.m. on weekdays and 7.00 a.m. to 1.30 p.m. on Saturdays (Sundays and public holidays excepted) Provided Always that at least one lift servicing each band of the
Building will remain operational on a twenty-four (24) hour basis; 

  

	 	(c)	electricity for the lighting of the passages, corridors, staircases, water-closets and other common parts of the Building; and 

  

	 	(d)	water for the common water-closets and toilet facilities in the Building. 

  

	 	(iii)	to keep the stairs, passages, corridors, common water-closets, lifts and other common parts of the Building well and sufficiently cleaned and lighted and to engage security services for the Building (but not so as to
render the Landlord liable for any loss sustained by the Tenant through the neglect, default, negligence or misconduct of any watchman or watchmen employed by the Landlord in connection with the provision of the said security services); and

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -11- 

	 	(iv)	to insure and keep insured the Building (excluding fittings and fixtures installed by the Tenant) against damage by fire and such other risks as the Landlord may deem fit. 

 

	 	4.3.2	Maintenance of toilets and common areas 

 Notwithstanding anything herein contained, in
the event that the Demised Premises consists of one whole wing of the floor, the Tenant shall be responsible at its own costs and expenses for the maintenance and repair of the toilets and common areas (including but not limited to the pantry areas)
serving exclusively the Demised Premises (hereinafter referred to as “Exclusive Use Common Areas”). 
  

	5.	LANDLORD NOT LIABLE 

  

	5.1	No claim by Tenant 

 Notwithstanding anything herein contained the Landlord shall not be
liable to the Tenant, nor shall the Tenant have any claim against the Landlord in respect of: 
  

	 	5.1.1	any failure or inability of or delay by the Landlord in fulfilling any of its obligations under this Tenancy Agreement or any interruption in any of the services mentioned in Clause 4.3.1 by reason of necessary repair
or maintenance of any installations or apparatus or damage thereto or destruction thereof or by reason of mechanical or other defect or breakdown or by reason of any circumstances beyond the Landlord’s control (including but not limited to
fire, flood, act of God, escape of water, riot, civil commotion, curfew, emergency, labour disputes or shortage of manpower, fuel, materials, electricity or water); or 

 

	 	5.1.2	any act, omission, default, misconduct or negligence of any porter, attendant or other servant or employee, independent contractor or agent of the Landlord in or about the performance or purported performance of any
duty relating to the provision of the services or any of them as mentioned in Clause 4.3.1; or 

  

	 	5.1.3	any act, omission, default, misconduct or negligence of any contractor nominated or approved by the Landlord pursuant to paragraph 5 of Schedule 11 and paragraph 4 of Schedule 14, and any such contractor
appointed by the Tenant shall not be deemed to be an agent or employee of the Landlord; or 

  

	 	5.1.4	any damage, injury or loss arising out of the leakage, breakage or defect of the piping, wiring, sprinkler system or other apparatus of the Landlord in or about UE Square and/or the structure of UE Square; or

  

	 	5.1.5	any damage, injury or loss caused by other tenants or persons in UE Square; or 

  

	 	5.1.6	any damage, injury or loss arising from or in connection with the use of the car parks in UE Square. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -12- 

 Clauses 5.1.1, 5.1.4, 5.1.5 and 5.1.6 of this Clause 5.1 shall apply for a case of negligence as
well as to any other cause(s) howsoever arising. 
  

	5.2	Transfer to Management Corporation 

 In the event UE Square is at any time hereafter
strata subdivided, then after the transfer of the management and operation of UE Square to the Management Corporation, the provision of services mentioned in Clause 4.3.1 (insofar as those services which are hereafter provided by the Management
Corporation) shall cease to be the obligation or responsibility of the Landlord. 
  

	5.3	Accidents 

  

	 	5.3.1	The Landlord shall not be responsible to the Tenant or to the Tenant’s employees, independent contractors, agents, invitees, licensees nor to any other persons for any: 

 

	 	(i)	accident, happening or injury suffered in the Demised Premises or UE Square; or 

  

	 	(ii)	damage to or loss of any goods or property sustained in UE Square (whether or not due to the negligence or misconduct of any security guards or the failure of any security system for which the Landlord is in any way
responsible); or 

  

	 	(iii)	act, omission, default, misconduct or negligence of any employee of the Landlord or any person acting under such employee in respect of the Demised Premises, the Building or UE Square, 

howsoever occurring. 
  

	6.	PROVISOS 

 The parties agree to the following provisos: 

 

	6.1	Proviso for re-entry 

  

	 	6.1.1	If and whenever during the Term: 

  

	 	(i)	any or any part of the Rent or Service Charge payable under this Tenancy Agreement shall be unpaid for fourteen (14) days after any of the days when they become due for payment (whether or not they shall have been
formally demanded); or 

  

	 	(ii)	the Tenant shall at any time fail or neglect to perform or observe any of the covenants, conditions or provisions contained in this Tenancy Agreement to be performed or observed by the Tenant and (where such breach is
capable of remedy) fail to remedy such breach within fourteen (14) days after receipt of written notice from the Landlord; or 

  

	 	(iii)	any distress or execution is levied on the Tenant’s goods and is not discharged within seven (7) days of such levy; or 

  

	 	(iv)	an event of insolvency shall occur in relation to the Tenant, 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -13- 

 it shall be lawful for the Landlord or any person or persons duly authorised by the Landlord for
that purpose to re-enter the Demised Premises (or any part thereof in the name of the whole) at any time (and even if any previous right of re-entry has been waived) and
to repossess the Demised Premises and the Term hereby created and this Tenancy Agreement shall absolutely cease and determine. 
  

	 	6.1.2	Re-entry in exercise of the rights contained in Clause 6.1.1 shall be without prejudice to any rights or remedies of the Landlord in respect of any breach of any of the covenants
by the Tenant contained in this Tenancy Agreement (including the breach in respect of which the re-entry is made). 

  

	 	6.1.3	Without prejudice to any other rights or remedies of the Landlord, the Tenant shall indemnify the Landlord from and against all costs, loss and damages, including but not limited to the loss of Rent and Service Charge
(payable by the Tenant had the Term been completed) and all costs and expenses incurred in any re-letting or attempted re-letting of the Demised Premises, suffered by
the Landlord consequential upon the Landlord exercising its rights of re-entry. 

  

	 	6.1.4	The expression “an event of insolvency” in Clause 6.1.1 includes (in relation to a company or other corporation which is the Tenant) inability of the company to pay its debts, entry into liquidation
either compulsory or voluntary (except for the purpose of amalgamation or reconstruction which has been previously approved by the Landlord), the passing of a resolution for winding up, the making of a proposal to the company and its creditors for a
composition in satisfaction of its debts or a scheme of arrangement of its affairs, the application to the court for the appointment of a judicial manager or the appointment of a receiver or judicial manager and (in relation to an individual who is
the Tenant) insolvency or inability to pay or having no reasonable prospect of being able to pay his debts as they fall due, any step being taken or the presentation of a bankruptcy petition for the bankruptcy of the Tenant, the making of a proposal
to his creditors for a composition in satisfaction of his debts or a scheme of arrangement of his affairs or the appointment of a receiver in respect of his property. 

 

	6.2	Power for Landlord to deal with adjoining property and the Demised Premises 

  

	 	6.2.1	The Landlord may deal as it may think fit with other property belonging to the Landlord adjoining or nearby and to erect or suffer to be erected on such property any buildings whatsoever whether or not such buildings
shall affect or diminish the light or air which may now or at any time be enjoyed by the Tenant in respect of the Demised Premises. 

  

	 	6.2.2	The Landlord shall have the right at all times without obtaining any consent from or making any arrangement with the Tenant to alter, reconstruct or modify in any way whatsoever or change the use of the parts of UE
Square (including all fixtures, fittings, machinery and apparatus therein and thereto), which are defined to be common property under the Land Titles (Strata) Act (Cap 158) or if UE Square is not subdivided and registered under the Land Titles
(Strata) Act (Cap 158), those parts of UE Square which would reasonably be deemed to be common property if UE Square had been subdivided and registered under that Act, so long as proper means of access to and egress from the Demised Premises are
afforded and essential services are maintained at all times. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -14- 

	 	6.2.3	Nothing contained in this Tenancy Agreement shall confer on the Tenant any right to enforce any covenant or agreement relating to other parts of UE Square demised by the Landlord to others, or limit or affect the right
of the Landlord in respect of any such other premises to deal with the same and impose and vary such terms and conditions in respect thereof in any manner as the Landlord may think fit. 

 

	6.3	Removal of property after determination of Term 

  

	 	6.3.1	If at such time as the Tenant has vacated the Demised Premises after the determination of this Tenancy Agreement, any property of the Tenant shall remain in or on the Demised Premises and the Tenant shall fail to remove
the same within seven (7) days after being requested by the Landlord so to do by a notice to that effect then the Landlord may as the agent of the Tenant sell such property and shall then apply the proceeds of sale after deducting the costs and
expenses of removal, storage and sale reasonably and properly incurred by the Landlord towards discharging any sum due from the Tenant to the Landlord under the provisions of this Tenancy Agreement and shall hold the balance thereof (if any) to the
order of the Tenant. 

  

	 	6.3.2	The Tenant shall indemnify the Landlord against any liability incurred by it to any third party whose property shall have been sold by the Landlord in the bona fide mistaken belief (which shall be presumed unless the
contrary be proved) that such property belonged to the Tenant and was liable to be dealt with as such pursuant to this clause. 

  

	6.4	Notices, consents and approvals 

  

	 	6.4.1	All notices, demands or other communications required or permitted to be given or made hereunder shall be in writing and shall be sufficiently served on the Tenant if the same is addressed to the Tenant and sent by
telefax to the Tenant’s-telefax number at the Demised Premises or delivered personally or sent by registered post to the Demised Premises. All notices, demands or other communications shall be
sufficiently served on the Landlord if the same is addressed to the Landlord and sent by registered post to the registered office for the time being of the Landlord. Any such notice, demand or communication shall be deemed to have been duly served
immediately (if given or made by facsimile or delivered by hand) or (if given or made by letter) twenty-four (24) hours after posting and in proving the same it shall be sufficient to show that the envelope containing the same was duly
addressed, stamped and posted. 

  

	 	6.4.2	Any consent or approval under this Tenancy Agreement shall be required to be obtained before the act or event to which it applies is carried out or done and shall be effective only when the consent or approval is given
in writing. 

  

	 	6.4.3	In any case where pursuant to this Tenancy Agreement or to any rule or regulation made hereunder, the doing or executing of any act, matter or thing by the Tenant is dependent upon the consent or approval of the
Landlord, such consent or approval may be given or withheld by the Landlord in its absolute discretion 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -15- 

	 	
(unless otherwise herein provided) and upon or subject to such terms, conditions, requirements or stipulations as the Landlord may think fit. The Tenant shall pay to the Landlord upon demand any
reasonable fees payable by the Landlord to consultants engaged by the Landlord to examine or advise upon application made by the Tenant (including any plans, specifications or material submitted therewith) for any consent or approval of the Landlord
required pursuant to this Tenancy Agreement or any rule or regulation made hereunder, and also any other moneys or expenses properly incurred in connection therewith. 

 

	6.5	Payments 

  

	 	6.5.1	The Tenant covenants to pay to the Landlord promptly as and when due without demand, deduction, set-off, or counterclaim whatsoever all sums due and payable by the Tenant to the
Landlord pursuant to the provisions of this Tenancy Agreement, and covenants not to exercise or seek to exercise any right or claim to withhold rent or any right or claim to legal or equitable set-off.

  

	6.6	Determination of Floor Area 

 The Landlord and the Tenant agree that the Floor Area
specified in paragraph 3 of Appendix A shall be final, conclusive and binding upon the parties. 
  

	6.7	Costs and expenses 

 The Tenant agrees to pay the Landlord (on a full indemnity basis):

  

	 	6.7.1	all the Landlord’s legal costs and fees incurred in connection with the preparation and completion of this Tenancy Agreement, the stamp duty and all other disbursements and out-of-pocket expenses in respect thereof; 

  

	 	6.7.2	all the Landlord’s legal costs and expenses incurred in enforcing any provision of this Tenancy Agreement in the event of a breach by the Tenant; 

 

	 	6.7.3	all the Landlord’s costs and expenses (including solicitors’ costs and costs of the Landlord’s architect, engineer or surveyor where applicable) incurred in connection with every application made by the
Tenant for any consent or approval required under this Tenancy Agreement whether or not such consent or approval shall be granted or given; and 

  

	 	6.7.4	all goods and services, value added and other duties or taxes payable on the costs, fees and expenses referred to in Clauses 6.7.1, 6.7.2 and 6.7.3 above. 

 

	6.8	Untenantability 

 If the Demised Premises or any part thereof shall at any time be
damaged or destroyed by fire so as to render the Demised Premises unfit for occupation and use (except where such damage or destruction has been caused by, or the policy or policies of insurance in relation to the Demised Premises shall have been
vitiated or payment of the policy monies withheld in whole or in part in consequence of, some act or default of the Tenant, its servants, independent contractors, agents or any permitted occupier) the Rent and Service Charge reserved by this Tenancy
Agreement or a fair and just proportion thereof according to the nature and extent of the damage sustained shall be suspended until the Demised Premises shall again be rendered fit for occupation and use, and any dispute 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -16- 

 
concerning this clause shall be determined by a single arbitrator in accordance with the Arbitration Act (Cap 10) Provided Always that the Landlord may in its absolute discretion decide that the
Demised Premises are so badly damaged that it will demolish and rebuild the Demised Premises instead of repairing the same and in any such event either party may within ninety (90) days after such damage has been sustained give written notice
to the other terminating this tenancy and thereupon this Tenancy Agreement shall terminate and the Tenant shall (if still in occupation) vacate the Demised Premises without compensation from the Landlord, but without prejudice to any right of action
of the Landlord in respect of any antecedent breaches of any covenant contained in this Tenancy Agreement on the part of the Tenant to be observed or performed. 
  

	6.9	No waiver 

 Knowledge or acquiescence by the Landlord of any breach by the Tenant of any
of the covenants, conditions or obligations herein contained shall not operate or be deemed to operate as a waiver of such covenants, conditions or obligations and any consent or waiver of the Landlord shall only be effective if given in writing. No
consent or waiver expressed or implied by the Landlord to or of any breach of any covenant, condition or obligation of the Tenant shall be construed as a consent or waiver to or of any other breach of the same or any other covenant, condition or
obligation and shall not prejudice in any way the rights, powers and remedies of the Landlord herein contained. Any acceptance by the Landlord of Rent or Service Charge reserved by this Tenancy Agreement or any other sum payable under this Tenancy
Agreement shall not be deemed to operate as a waiver by the Landlord of any right to proceed against the Tenant in respect of a breach by the Tenant of any of the Tenant’s obligations hereunder. 

 

	6.10	No representations 

 The Landlord shall not be bound by any representations or promises
with respect to the Building and its appurtenances, or in respect of the Demised Premises, except as expressly set forth in this Tenancy Agreement with the object and intention that the whole of the agreement between the Landlord and the Tenant
shall be set forth herein, and shall in no way be modified by any discussions which may have preceded the signing of this Tenancy Agreement. 
  

	6.11	Name of UE Square 

  

	 	6.11.1	The Landlord shall have the right at all times without obtaining any consent from the Tenant, to change the name or number by which UE Square is known. 

 

	 	6.11.2	The Tenant shall not use the name of UE Square as part of its trade or business name, other than as its address and place of business. The Tenant shall not use a name, trade mark or service mark which includes the name
of UE Square or any derivative name sounding similar thereto for any purpose whatsoever. 

  

	6.12	Rules and regulations 

  

	 	6.12.1	The Landlord shall have the right at any time and from time to time to make, add to, amend, cancel or suspend such rules and regulations in respect of UE Square as in the judgment of the Landlord may from time to time
be required for the management, safety, care or cleanliness of UE Square or for the preservation of 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -17- 

	 	
good order therein or for the convenience of tenants and all such rules and regulations shall bind the Tenant, the Tenant’s employees, independent contractors, agents, visitors, invitees,
licensees and permitted occupiers upon and from the date on which notice in writing thereof is given to the Tenant by the Landlord Provided Always that the Landlord shall not be liable to the Tenant in any way for violation of the rules and
regulations by any person including other tenants of UE Square or the employees, independent contractors, agents, visitors, invitees or licensees of any such persons. If there shall be any inconsistency between the provisions of this Tenancy
Agreement and the provisions of such rules and regulations then the provisions of this Tenancy Agreement shall prevail. 

  

	6.13	Holding over 

  

	 	6.13.1	If the Tenant continues to occupy the Demised Premises beyond the expiration or determination of the Term or fails to deliver vacant possession thereof to the Landlord after the expiration or determination of the Term,
with the Landlord’s acquiescence and without any express agreement between the Landlord and the Tenant, the Tenant shall do so as a monthly tenant and shall pay to the Landlord for every month of such holding over double the amount of Rent and
Service Charge or prevailing market rent whichever is higher and such holding over shall not constitute a renewal of this tenancy and there shall be no renewal of this tenancy by operation of law or pursuant to the provisions of this Tenancy
Agreement. During the period of any such holding over all other provisions of this Tenancy Agreement shall be and remain in effect. Such tenancy shall be determinable at any time by either the Landlord or the Tenant giving to the other one
month’s notice in writing. The provisions herein shall not be construed as the Landlord’s consent for the Tenant to hold over after the expiration or determination of the Term. 

 

	6.14	Changes to Plans 

  

	 	6.14.1	The Landlord may from time to time amend the development plans and/or the building plans for the Building and UE Square, such amendment may include but is not limited to, altering the floor plans of the Building and UE
Square changing the arrangement, location or converting the use of entrances, passageways, doors, doorways, partitions, corridors, landings, staircases, lobbies, lifts, toilets, car parks or other public parts of the Building and UE Square, changing
any services, apparatus and other common facilities serving the Building and UE Square, increasing the total net floor area approved for office· or other use within the Building and UE Square, or enlarging, varying or reducing the size of the
units in the Building and UE Square provided that any such amendment shall be approved by the relevant government authorities. 

  

	6.15	Landlord’s right to assign 

  

	 	6.15.1	The Landlord shall be entitled to assign all its rights and interest and obligations under this Tenancy Agreement. 

  

	 	6.15.2	The Tenant hereby expressly acknowledges and undertakes to the Landlord that where the Landlord assigns its rights and interest in under or arising out of this Tenancy Agreement (including the transfer of the Security
Deposit), the Tenant 

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -18- 

	 	
shall be deemed to have consented to such assignment and shall accept any assignee of the Landlord as its new landlord and the Tenant shall release the Landlord from all its obligations under the
provisions of this Tenancy Agreement and in particular the obligation of the Landlord to refund the Security Deposit and any other sums pursuant to the terms of this Tenancy Agreement. Where required by the Landlord, the Tenant shall enter into and
execute any novation agreement or assignment entered into or to be entered into by the Landlord and its assignee, such novation agreement or assignment to be prepared by and at the expense of the Landlord. 

 

	6.16	Severance 

  

	 	6.16.1	The illegality, invalidity or unenforceability of any provision of this Tenancy Agreement under the law of any jurisdiction shall not affect its legality, validity or enforceability under the law of any other
jurisdiction nor the legality, validity or enforceability of any other provision. 

  

	6.17	Governing law and submission to jurisdiction 

  

	 	6.17.1	This Tenancy Agreement shall be construed and governed by the laws of Singapore. 

  

	 	6.17.2	In relation to any legal action or proceeding arising out of or in connection with this Tenancy Agreement (“Proceedings”), the parties hereby irrevocably submit to the jurisdiction of the courts of
Singapore and waive any objection to Proceedings in any such court on the grounds of venue or on the grounds that the Proceedings have been brought in an inconvenient forum. Such submission shall not affect the right of any party to take Proceedings
in any other jurisdiction nor shall the taking of Proceedings in any jurisdiction preclude any party from taking Proceedings in any other jurisdiction. 

  

	 	6.17.3	The Tenant hereby irrevocably agrees and accepts that any writ, statement of claim or other legal process in relation to any Proceedings against the Tenant, shall be sufficiently served on the Tenant if sent by
registered post to the Demised Premises. 

  

	 	6.17.4	Nothing shall affect the right to serve process in any other manner permitted by law. 

  

	6.18	Provisions for Renewal 

 If the Tenant wishes to be granted a further tenancy term for
the Demised Premises, the provisions set out in Schedule 16 shall apply. 
  

	6.19	Contracts (Rights of Third Parties) Act (Cap 53B) 

 A person who is not a party to this
Tenancy Agreement has no right under the Contracts (Rights of Third Parties) Act (Cap 53B) to enforce any term of this Tenancy Agreement. 
  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -19- 

 Appendix A 

 

	1.	Tenant 

  

					
	Name	  	:	  	Aslan Pharmaceuticals Pte. Ltd.
			
	Company registration no.	  	:	  	201007695N
			
	Country of incorporation	  	:	  	Singapore
			
	Address of registered office	  	:	  	 10A Bukit Pasoh Road
 Singapore
08924

			
	Telefax number	  	:	  	
			
	Telephone number	  	:	  	

  

	2.	Demised Premises 

 All the premises on the
12th storey of the Building known as 83 Clemenceau Avenue, UE Square, Singapore and numbered #12-03. 

 

	3.	Floor Area 

 4,500 square feet 

 

	4.	Term of tenancy 

 Three (3) years from 1 October 2016 to 30 September 2019

  

	5.	Possession Date 

 1 September 2016 

 

	6.	Fitting Out Deposit 

 $3,000.00 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -20- 

	7.	Security Deposit 

 $94,500.00 

 

	8.	Monthly Rent rate 

 $5.95 per square foot 

 

	9.	Initial monthly Rent 

 $26,775.00 per month 

 

	10.	Monthly Service Charge rate 

 (subject to increase) 

$1.05 per square foot 
  

	11.	Initial monthly Service Charge 

 $4,725.00 per month 

 

	12.	Renewed Term 

 Three (3) years 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -21- 

 Schedule 1 

TOGETHER WITH (but to the exclusion of all other liberties, easements, rights or advantages): 

 

	FIRSTLY	the right for the Tenant and others duly authorised by the Tenant of ingress to and egress from the Demised Premises in over and along all the usual entrances, landings, lifts, lobbies and corridors leading thereto in
common with the Landlord and all others so authorised by the Landlord and all other persons entitled thereto, such right being only so far as is necessary and as the Landlord can lawfully grant; and 

 

	SECONDLY	the right for the Tenant and others duly authorised by the Tenant to use such sufficient toilet facilities in the Building as shall be designated from time to time in writing by the Landlord but such user shall be in
common with the Landlord and all others so authorised by the Landlord and all other persons entitled thereto. 

  

	THIRDLY	the right for the Tenant and all others authorised by the Tenant to enjoy the benefit of the air-conditioning system installed in the Building (subject to the obligation of the
Tenant to connect the same to the air-conditioning distributing ducts installed or to be installed by the Tenant in the Demised Premises) in common with the Landlord and all other persons entitled thereto.

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -22- 

 Schedule 2 

EXCEPTING AND RESERVING unto the Landlord: 
  

	1.	the right to the free and uninterrupted passage and running of water, gas, sewage, electricity, air-conditioning services, telephone and other services or supplies from and to
other parts of the Building and/or UE Square in and through the Conducting Media and ancillary apparatus which now are or may during the Term be in, on, under or over the Demised Premises. 

 

	2.	all rights of entry upon the Demised Premises referred to in Clause 3 of this Tenancy Agreement. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -23- 

 Schedule 3 

Tenant’s Works 

(referred to in Clause 2.4) 
  

	1.	The Tenant shall accept the Demised Premises in its existing state and condition with full knowledge of all structural, mechanical and electrical specifications of the Demised Premises as set out in the Tenant’s
Fitting Out Brief. The Tenant shall carry out at the Tenant’s own costs and expenses all works required by the Tenant for purpose of fitting out the Demised Premises and shall comply with and observe the guidelines, terms and conditions set out
in the Tenant’s Fitting Out Brief. 

  

	2.	Prior to the commencement of the Tenant’s Works, the Tenant shall at its own costs and expense engage consultants approved by the Landlord, to consider and approve the layout and specifications for the
Tenant’s Works and to assist the Tenant in the submission of plans and the supervision of all works to be carried out by the Tenant. The fees and expenses of such consultants shall be borne by the Tenant and forthwith paid by the Tenant when
they fall due. Such consultants shall not be deemed to be agents or employees of the Landlord and the Tenant shall not have any claim whatsoever against the Landlord in respect of any act, omission, default, misconduct or negligence of any such
consultants. 

  

	3.	Prior to the commencement of the Tenant’s Works, the Tenant shall at its own costs and expense submit to the Landlord for approval all plans, layouts, designs, drawings and specifications for the Tenant’s
Works (including details of proposed materials to be used for the Tenant’s Works) before the Tenant submits the same to any relevant government authority for the approval. The Landlord shall be entitled to engage its architect, engineer or
other consultant(s) for the purpose of considering the plans, specifications and materials relating to the Tenant’s Works, the fees and expenses of such architect, engineer and consultant(s) incurred in connection therewith shall be borne by
the Tenant and forthwith paid by the Tenant to the Landlord on demand. If the Tenant fails to make payment on demand, the Landlord may effect payment of the same and all expenses so incurred by the Landlord together with Interest from the date of
expenditure until the date they are paid by the Tenant to the Landlord, shall be recoverable from the Tenant as if they were rent in arrears. All drawings and plans in respect of the Tenant’s Works (including drawings and plans in respect of
mechanical and electrical and structural works) which have been submitted to and approved by the Landlord, shall be endorsed by the Project Consultants, for purpose of submission to the relevant government authorities for approval.

  

	4.	The Tenant shall apply for and obtain the Requisite Consents in relation to the Tenant’s Works. 

  

	5.	Prior to the commencement of the Tenant’s Works, the Tenant shall effect and maintain at the Tenant’s cost and expense, a comprehensive public liability policy, covering the period from the date of
commencement of the Tenant’s Works to the date of completion of the Tenant’s Works for an adequate amount or such higher amounts as the Landlord may from time to time prescribe with a reputable insurance company naming the Landlord, the
Landlord’s main contractor and the Tenant’s fitting out contractor as the co-insured parties for their respective rights and interests. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -24- 

	6.	Prior to the Tenant taking possession of the Demised Premises, the Tenant shall deposit with the Landlord the Fitting Out Deposit as security for (i) the Tenant making good to the satisfaction of the Landlord all
damage to the Demised Premises and the Building resulting from the execution of the Tenant’s Works, (ii) the Tenant removing all waste materials and debris arising from non-structural addition and
alteration works relating to the Tenant’s Works and (iii) the due compliance by the Tenant of the provisions of the Tenant’s Fitting Out Brief. 

If the Tenant fails to comply with the provisions of (i), (ii) and (iii) above, the Landlord may effect the necessary works, and apply
the Fitting Out Deposit in meeting the costs and expenses so incurred by the Landlord, and the Fitting Out Deposit subject to any deductions to be made by the Landlord pursuant to the provisions herein, shall be repaid to the Tenant, without
interest, within one (1) month after the proper completion of the Tenant’s Works (in compliance with the provisions of this Schedule 3 and the making good of the damage (if any) to the Demised Premises and the Building as aforesaid.

 If the Fitting Out Deposit shall be insufficient, the Tenant shall pay to the Landlord on demand all expenses so incurred with Interest
from the date of expenditure until the date they are paid by the Tenant to the Landlord (such expenses and Interest to be recoverable as if they were rent in arrears). 
  

	7.	Following the approval of the Landlord and the obtaining of the Requisite Consents, the Tenant shall proceed to carry out and complete the Tenant’s Works to the Landlord’s reasonable satisfaction:

  

	 	(a)	in accordance with the plans, layouts, designs, drawings, specifications and other details approved by the Landlord; 

  

	 	(b)	with good and suitable materials of a type, quality, colour and standard approved by the Landlord; 

  

	 	(c)	in a good and workmanlike manner in accordance with good building practice and in compliance with the reasonable requirements of the Landlord’s architect; 

 

	 	(d)	so as not to cause any obstruction or interference with the works of other tenants or occupiers of the Building; 

  

	 	(e)	in accordance with the Requisite Consents in relation to the Tenant’s Works; 

  

	 	(f)	in accordance with the guidelines, terms and conditions set out in the Tenant’s Fitting Out Brief; 

  

	 	(g)	in compliance with all statutes, orders and regulations made under codes of practice of local authorities and competent authorities affecting the Tenant’s Works and/or the Demised Premises; and 

 

	 	(h)	with due diligence. 

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -25- 

	8.	The Tenant’s Works shall only be carried out: 

  

	 	(a)	in the case of any installation works in respect of the airconditioning and mechanical ventilation system, fire-fighting and alarm system, telecommunication, security and closed-circuit television system and building
automation system and any electrical engineering works, by specialist contractors nominated by the Landlord and separately employed by the Tenant in relation to the Tenant’s Works; and 

 

	 	(b)	in all other cases by engineers or contractors appointed by the Tenant with the approval of the Landlord. 

A contractor or engineer nominated or approved by the Landlord pursuant to this paragraph shall not be deemed to be an agent or employee of
the Landlord and the Tenant shall not have any claim whatsoever against the Landlord in respect of any act, omission, default, misconduct or negligence of any such contractor. 

 

	9.	The Tenant shall permit the Landlord and its servants or agents at all reasonable times to enter into and inspect and view the Demised Premises to ascertain if the Tenant’s Works are or have been carried out in
accordance with the provisions of this Schedule 3. If any breach of the provisions of this Schedule 3 shall be found upon such inspection, the Tenant shall upon notice by the Landlord take all necessary steps for the rectification of
such breach. 

  

	10.	The Tenant shall indemnify and keep the Landlord indemnified against: 

  

	 	(a)	the breach, non-observance or non-performance of any Requisite Consents in relation to the Tenant’s Works; and 

 

	 	(b)	any claims, demands or proceedings brought by any adjoining owner, tenant, occupier or member of the public arising out of or incidental to the execution of the Tenant’s Works. 

 

	11.	Any delay in carrying out or completing the Tenant’s Works shall not be a ground for postponing the commencement of the Term or payment of Rent, Service Charge and other moneys reserved by this Tenancy Agreement,
or relieve in any way the Tenant from the performance and observance of the obligations, covenants, conditions and provisions on the Tenant’s part to be performed and observed. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -26- 

 Schedule 4 

Rent Provisions 
  

	1.	Tenant’s liability to pay Rent 

  

	1.1	The Tenant shall pay to the Landlord the monthly Rent by equal monthly payments in advance on the first day of each month (each a “Payment Date”). 

 

	1.2	On or before the date of commencement of the Term, the Tenant shall pay to the Landlord the pro-rated Rent calculated from the date of commencement of the Term up to and including
the day immediately preceding the next Payment Date, and thereafter the Rent shall be paid on each succeeding Payment Date. 

  

	2.	Calculation of Rent 

  

	2.1	The Rent payable in respect of the Demised Premises shall be calculated at the monthly rate set out in paragraph 8 of Appendix A, on the basis of the Floor Area of the Demised Premises. The initial monthly Rent
payable by the Tenant calculated on the Floor Area set out in paragraph 3 of Appendix A shall be the sum set out in paragraph 9 of Appendix A. 

  

	3.	Rent Free Period 

 The Landlord shall grant the Tenant a Rent Free Period (free of
Gross Rent) of 0.5 month for the period from 15 September 2019 to 30 September 2019. 
  

	3.2	In the event that the Term of the Tenancy is prematurely terminated by the Tenant for any reason whatsoever or the same is determined by the Landlord in consequence of the Tenant’s breach of the terms and
conditions applicable thereto, the Tenant shall compensate and pay to the Landlord on demand an amount calculated at the monthly rate equivalent to the Rent and Service Charge which could have been applicable if the rent free period constituted part
of the Term of the Tenancy and for the entire duration of the Rent Free Period. This right is only enforceable in the event of non performance under the Tenancy Agreement whereby the Landlord is, per the Tenancy Agreement, permitted to terminate the
Tenancy. 

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -27- 

 Schedule 5 

Service Charge Provisions 
  

	1.	Tenant’s liability to pay Service Charge 

  

	1.1	The Tenant shall pay to the Landlord during the Term, a monthly Service Charge based on the monthly Service Charge rate set out in paragraph 10 of Appendix A (subject to increase as hereinafter provided)
calculated on the Floor Area of the Demised Premises, such Service Charge shall be paid on the same days upon which Rent is payable under this Tenancy Agreement. The monthly Service Charge payable by the Tenant in respect of the Demised Premises
calculated on the Floor Area set out in paragraph 3 of Appendix A shall be the sum set out in paragraph 11 of Appendix A. 

  

	1.2	The Service Charge shall be calculated on the basis of the Apportioned Outgoings (as defined in paragraph 2). 

  

	1.3	The Landlord shall be entitled at any time and from time to time to increase the Service Charge by written notice in that behalf subject to the provisions hereinafter contained. 

 

	1.4	If (i) the actual amount of Total Outgoings (as defined in paragraph 2) incurred during the first year of the Term exceeds the amount of Total Outgoings on which the monthly Service Charge rate set out in
paragraph 10 of Appendix A was calculated or (ii) in respect of any subsequent period of the Term, there is any increase in the Total Outgoings, the Tenant shall be liable to pay an increased amount of Service Charge in each and every
month. A written notice by the Landlord (the “Landlord’s Notice”) stating the amount of the increase in the Service Charge on a per square foot basis and the effective date of such increase shall be accepted by the Tenant as
conclusive and binding of the matters so stated. The increase in Service Charge shall be chargeable and payable with effect from the date specified in the Landlord’s Notice. If there shall be any additional Service Charge payable from a date
prior to the issuance of the Landlord’s Notice, the aggregate amount of such additional Service Charge shall be payable by the Tenant forthwith upon the issuance of the Landlord’s Notice. Additional Service Charge for the period after the
issuance of the Landlord’s Notice shall be added to the prevailing Service Charge and such aggregate sum shall be and remain the Service Charge until further increased by the Landlord under this paragraph 1. 

 

	1.5	The provisions of this Schedule 5 shall continue to apply notwithstanding the expiry or earlier determination of the Term but only in respect of the tenancy period down to the expiry or earlier determination of
this Tenancy Agreement. 

  

	2.	Definitions 

 For purpose of this Schedule 5: 

“Apportioned Outgoings” means the portion of Total Outgoings as shall be Attributable to the Demised Premises. 

“Attributable to the Demised Premises” means the proportion of the Total Outgoings determined by the Landlord by reference to
the proportion which the Floor Area of the Demised Premises bears towards the Net Area of the Office Premises. 
  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -28- 

 “Net Area of the Office Premises” means the total area of rentable floor space
designated from time to time for use as office space (including any floor space occupied by the Landlord) in the Building as determined by the Landlord. 

“Office Premises” means all that portion of the Building comprising the strata lot areas approved for use as office and other
approved uses situate on the 2nd storey to the 18th storey (both inclusive) of the Building. 
 “Office Premises Common
Area” means those parts of the Office Premises which the Landlord provides or designates from time to time for the general use by or for the benefit of the Tenant and its permitted occupiers in common with other tenants, occupiers and users
of the Office Premises, including but not limited to common passages, corridors, staircases, waterclosets and the areas used to contain or for the maintenance of the plant, equipment and installations necessary for the provision of the Office
Premises Common Facilities. 
 “Office Premises Common Facilities” means the mechanical and electrical services and other
amenities, facilities and services provided by the Landlord from time to time to serve the Demised Premises and the Office Premises and for general use by or for the benefit of the Tenant and its permitted occupiers in common with other tenants,
occupiers and users of the Office Premises. 
 “Total Outgoings” means the total sum of all outgoings, costs and expenses of
the Landlord assessed or assessable, charged or chargeable, paid or payable or otherwise incurred by the Landlord in relation to the following matters: 
  

	 	(a)	The expenses paid or payable by the Landlord as contributions towards the costs of services and maintenance for the Common Property of UE Square and attributable to the Office Premises, such contributions to include all
amounts paid or payable to the Management Corporation in respect of amounts levied from time to time by Management Corporation on the Office Premises; 

  

	 	(b)	all amounts payable in respect of insurances (including but not limited to fire, public liability, theft/ burglary, workmen’s compensation, common law liability insurance) relating to the Office Premises Common
Area and Office Premises Common Facilities and all the plant, machinery, equipment, installations, appliances and all Conducting Media in relation thereto, and for the personnel engaged in the operation and maintenance of the Office Premises Common
Area and Office Premises Common Facilities; 

  

	 	(c)	all costs in relation to the management, control and administration of the Office Premises Common Area and Office Premises Common Facilities including without limitation the employment or engagement of engineers,
maintenance staff, security staff and other personnel engaged in the operation and maintenance of the Office Premises Common Area and Office Premises Common Facilities; 

 

	 	(d)	the cost of uniforms, salaries, wages, bonuses, allowances and other emoluments, remuneration and benefits of all personnel engaged in the operation and maintenance of the Office Premises Common Area and Office Premises
Common Facilities as well as payroll tax and Central Provident Fund and other statutory contributions or charges in respect thereof; 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -29- 

	 	(e)	all costs of operating and maintaining the Office Premises Common Area and Office Premises Common Facilities and supplying all services from time to time provided for tenants and occupiers of the Office Premises
including but without limiting the generality of the foregoing, repairs and replacements, repainting and redecorating of the Office Premises Common Area and Office Premises Common Facilities and the maintenance, repair, renovation, renewal,
replacement and amortization of all lifts, escalators, air-conditioning plant, fire and security alarm systems, fire-fighting equipment and other plant and equipment required in connection with any of such
services, and all Conducting Media in relation thereto; 

  

	 	(f)	all costs and charges (including taxes thereon) for lighting, power, air-conditioning and ventilation incurred in connection with the Office Premises Common Area and Office
Premises Common Facilities; 

  

	 	(g)	all charges for and costs in relation to the supply of water to and removal of all sewerage, waste and other garbage from the Office Premises Common Area and the Office Premises Common Facilities; 

 

	 	(h)	all costs and charges for the cleaning of the Office Premises Common Area; 

  

	 	(i)	all expenses of supplying toilet paper, soap and other toilet requisites in the water-closets, washrooms and lavatories of the Office Premises Common Area; 

 

	 	(j)	all fees and charges of managing agents employed for the carrying out and provision of services for the Office Premises Common Area and Office Premises Common Facilities; 

 

	 	(k)	all fees and charges of auditors, accountants and other professional consultants engaged in connection with the provision of services for the Office Premises Common Area and Office Premises Common Facilities;

  

	 	(I)	all sums in each year as may be set aside as a fund to cover repairs, renovations, painting, replacements and maintenance of a substantial but infrequent or irregular nature of the Office Premises Common Area and Office
Premises Common Facilities and the plant machinery and electrical and other apparatus therein including lifts, air-conditioning plant, fire fighting, security, alarm equipment and all Conducting Media in
relation thereto; and 

  

	 	(m)	all items of expenditure incurred in carrying out all other works, acts, matters or things or in providing all such other services or amenities of any kind whatsoever in relation to the Office Premises Common Area and
Office Premises Common Facilities. 

  

	3.	No objection by Tenant 

 The Tenant shall not be entitled to object to any item of costs
comprised in the Total Outgoings or otherwise on any of the following grounds: 
  

	3.1	the inclusion in a subsequent accounting period of any item of expenditure or liability omitted from the computation of the Total Outgoings for any preceding accounting period; or 

 

	3.2	the exclusion in a subsequent accounting period of any item of expenditure or liability included in the computation of the Total Outgoings for any preceding accounting period; or 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -30- 

	3.3	an item of charge included at a proper cost might have been provided or performed at a lower cost; or 

  

	3.4	disagreement with any estimate of future expenditure for which the Landlord requires to make provision so long as the Landlord has acted in good faith and in the absence of manifest error; or 

 

	3.5	the manner in which the Landlord exercises its discretion in providing services so long as the Landlord acts in good faith and in accordance with the principles of good estate management; or 

 

	3.6	the employment of managing agents to carry out and provide on the Landlord’s behalf services under this Schedule 5. 

  

	4.	After taking over by Management Corporation 

  

	4.1	After the taking over by the Management Corporation of the maintenance and management of the Building and UE Square, the Service Charge payable by the Tenant shall be all such contributions (and any revisions thereof)
as may from time to time be levied in respect of the Demised Premises by the Management Corporation for the purpose of the Management Corporation meeting actual or expected liabilities referred to in section 48(1)(m) and (n) of the Land Titles
(Strata) Act (Cap 158) and for the establishment of the management fund and sinking fund referred to in section 48(1)(o) and (p) of the said Act. If the Demised Premises comprise part of a subsidiary strata lot, the aforesaid contributions levied by
the Management Corporation in respect of that subsidiary strata lot, shall be pro-rated according to the strata title area of the relevant subsidiary strata lot, and the Tenant shall pay a proportionate part
of such contributions attributable to the Demised Premises, the Landlord’s statement of such apportionment to be conclusive as to the amount thereof. 

  

	4.2	The Service Charge referred to in paragraph 4.1, shall be paid to the Landlord on the same days upon which Rent is payable under this Tenancy Agreement. 

 

	4.3	The provisions of this paragraph 4 shall continue to apply notwithstanding the expiry or earlier determination of this tenancy. 

  

	5.	Maintenance and cleaning of toilets and common areas (only applicable for full wing Tenant) 

Notwithstanding anything herein contained, in the event that the Demised Premises consists of one (1) whole wing of the floor, the Tenant
shall be responsible at its own costs and expenses for the maintenance and cleaning of the Exclusive Use Common Areas. 
  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -31- 

 Schedule 6 

(referred to in Clauses 3.1.2, 3.1.3 and 3.1.4) 

Interest and Taxes 
 The Tenant hereby
covenants with the Landlord as follows: 
  

	1.	If the whole or any part of the Rent, Service Charge and other monies due under this Tenancy Agreement shall remain unpaid fourteen (14) days after they shall have become due (whether such Rent, Service Charge or
other monies be formally demanded or not) or if the Landlord shall refuse to accept the tender of Rent, Service Charge or other monies because of a breach of covenant on the part of the Tenant, then to pay Interest on such Rent (or part thereof),
Service Charge (or part thereof) and other monies, as from the date they became due until they are paid to (or accepted by) the Landlord and such Interest shall be recoverable from the Tenant as if they were rent in arrears. Nothing in this
paragraph 1 shall entitle the Tenant to withhold or delay any payment of the Rent or Service Charge or any other sum due under this Tenancy Agreement after the date upon which they fall due or in any way prejudice affect or derogate from the rights
of the Landlord in relation to such non-payment including (but without prejudice to the generality of the above) under the proviso for re-entry contained in this Tenancy
Agreement. 

  

	2.	It is hereby agreed that the Rent, Service Charge and other sums payable by the Tenant under this Tenancy Agreement (hereinafter collectively called “the Agreed Sum”) shall, as between the Landlord and
the Tenant be exclusive of any applicable goods and services tax, imposition, duty and levy whatsoever (hereinafter collectively called “Taxes”) which may from time to time be imposed or charged before, on or after the commencement
of this tenancy (including any subsequent revisions thereto) by any government, quasi-government, statutory or tax authority (hereinafter called “the Authorities”) on or calculated by reference to the amount of the Agreed Sum (or
any part thereof) and the Tenant shall pay all such Taxes or reimburse the Landlord for the payment of such Taxes, as the case may be, in such manner and within such period as to comply or enable the Landlord to comply with any applicable orders or
directives of the Authorities and the relevant laws and regulations. 

 If the Landlord or the Tenant (or any person on their
behalf) is required by law to make any deduction or withholding or to make any payment, on account of such Taxes, from or calculated by reference to the Agreed Sum (or any part thereof): 

 

	 	(a)	The Tenant shall pay, without requiring any notice from the Landlord all such Taxes for its own account (if the liability to pay is imposed on the Tenant), or on behalf of and in the name of the Landlord (if the
liability to pay is imposed on the Landlord) on receipt of written notice from the Landlord, and without prejudice to the foregoing, if the law requires the Landlord to collect and to account for such Taxes, the Tenant shall pay such Taxes to the
Landlord (which shall be in addition to the Tenant’s liability to pay the Agreed Sum) on receipt of written notice from the Landlord; and 

  

	 	(b)	the sum payable by the Tenant in respect of which the relevant deduction, withholding or payment is required on account of such Taxes, shall be increased 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -32- 

	 	
to the extent necessary to ensure that after the making of the aforesaid deduction, withholding or payment, the Landlord or any person or persons to whom such sum is to be paid, receives on due
date and retains (free from any liability in respect of any such deduction, withholding or Taxes) a net sum equal to what would have been received and retained had no such deduction, withholding or payment been required or made. 

The rights of the Landlord under this paragraph 2 shall be in addition and without prejudice to any other rights or powers of the Landlord
under any applicable order or directive of the Authorities or any relevant law or regulation, to recover from the Tenant the amount of such Taxes which may be or is to be paid or borne by the Landlord. 

The Tenant shall indemnify and hold harmless the Landlord from any losses, damages, claims, demands, proceedings, actions, costs, expenses,
interests and penalties suffered or incurred by the Landlord arising from any claim, demand, proceeding or action that may be made or instituted by the Authorities in respect of such Taxes and resulting from any failure or delay on the part of the
Tenant in the payment and discharge of any such Taxes. Without prejudice to any of the foregoing provisions, the Tenant shall pay and reimburse the Landlord for all goods and services tax which may from time to time be imposed or charged before, on
or after the commencement of this tenancy in respect of any supply which may be determined by the Comptroller of Goods and Services Tax under or in connection with the occupation and tenancy of the Demised Premises and the Tenant shall indemnify and
hold harmless the Landlord from any losses, damages, claims, demands, proceedings, actions, costs, expenses, interests and penalties suffered or incurred by the Landlord in respect of any such goods and services tax. 

 

	3.	Property tax imposed or levied by the relevant government authority on the Demised Premises or on the Building or on UE Square (or any part thereof) and as may be apportioned by the Landlord or attributable to the
Demised Premises shall be paid as follows: 

  

	 	(a)	The Landlord shall for the duration of the Term pay property tax levied on or attributable to the Demised Premises but such payment by the Landlord in respect of the Demised Premises shall not exceed property tax
calculated (i) on the basis of an annual value equivalent to the annual Rent payable under this Tenancy Agreement; and (ii) at the property tax rate applicable on first assessment of property tax. In the event that any additional property
tax levied by the relevant authority on or apportioned by the Landlord as attributable to the Demised Premises is payable on account of (i) the annual value assessed by the relevant government authority or apportioned by the Landlord as
attributable to the Demised Premises (whether on first assessment by the relevant government authority or as increased from time to time whether retrospective or otherwise) which is in excess of the annual value calculated as aforesaid by reference
to the annual Rent; and/or (ii) an increase in the property tax rate above the rate applicable on first assessment, such additional property tax shall be borne and paid by the Tenant to the Landlord on demand. 

 

	 	(b)	In the event that the Landlord grants to the Tenant rent free periods or rent rebates during the Term, the provisions of this paragraph 3(b) shall apply in 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -33- 

	 	
substitution of the provisions of paragraph 3(a). The Landlord shall for the duration of the Term pay property tax levied on or attributable to the Demised Premises but such payment by the
Landlord in respect of the Demised Premises shall not exceed property tax calculated (i) on the basis of an annual value equivalent to the annual Effective Rent payable by the Tenant under this Tenancy Agreement; and (ii) at the property
tax rate applicable on first assessment of property tax. In the event that any additional property tax levied by the relevant authority on or apportioned by the Landlord as attributable to the Demised Premises is payable on account of (i) the
annual value assessed by the relevant government authority or apportioned by the Landlord as attributable to the Demised Premises (whether on first assessment by the relevant government authority or as increased from time to time whether
retrospective or otherwise) which is in excess of the annual value calculated as aforesaid by reference to the annual Effective Rent; and/or (ii) an increase in the property tax rate above the rate applicable on first assessment, such
additional property tax shall be borne and paid by the Tenant to the Landlord on demand. 

 For purpose of this paragraph, the
annual “Effective Rent” is calculated by using the following formula: 
 annual 

 

									
	Effective Rent =	  	A	  	×	  	12	  	
		  	B	  		  		  	

 where 
  

	 	A :	refers to the total aggregate amount of Rent payable by the Tenant for the entire duration of the Term, taking into account the rent free periods and rent rebates. 

 

	 	B :	the number of months comprising the entire duration of the Term. 

  

	 	(c)	The Tenant’s liability in respect of any additional property tax referable to the Term of this tenancy, pursuant to the provisions of this paragraph 3 of Schedule 6 shall not be affected by the expiry or
earlier determination of this tenancy. 

  

	 	(d)	Objection to any assessment of annual value or imposition of property tax on the Demised Premises during the Term may be made only by the Landlord in its sole discretion. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -34- 

 Schedule 7 

(referred to in Clause 3.2) 

Utilities 
 The Tenant hereby covenants
with the Landlord as follows: 
  

	1.      (a)	To pay all charges including any taxes now or in the future imposed by the Designated Supplier or other appropriate authority in respect of electricity and/or chilled water supplied to all
air-conditioning fan coil units and any other services supplied and metered separately to the Demised Premises which shall be consumed or supplied on or to the Demised Premises, and to pay all necessary hire
charges for any equipment or appliances supplied to the Tenant irrespective of whether the same was installed by the Landlord or the Tenant and whether the electricity and/or chilled water is supplied during or beyond the operating hours of the
Building and whether invoiced by a Designated Supplier, other supplier or by the Landlord, and all transmission and transportation charges payable in connection with the supply of such electricity and/or chilled water supplied to all air-conditioning fan coil units and any other services supplied. 

  

	 	(b)	To arrange at its own costs and expenses for the installation and testing of the meter and any equipment or appliances required to separately measure the services supplied to the Demised Premises and for licensed
electrical contractors to apply to the Designated Supplier for such installations and testing. 

  

	 	(c)	Without prejudice to the foregoing, in the event of such electricity or other services not being supplied and metered separately to the Demised Premises, to pay to the Landlord a proportionate part of the cost thereof,
such cost to be calculated by the Landlord and notified to the Tenant by a statement from the Landlord in writing, such statement to be conclusive as to the amount thereof, and in the event of the Designated Supplier or other equivalent authority
responsible for the supply of electricity and any other services supplied and used in the Building increasing the charges therefor, the Tenant shall pay to the Landlord a proportionate part of the increased costs thereof, such costs to be calculated
by the Landlord and notified to the Tenant by a statement from the Landlord in writing, such statement to be conclusive as to the amount thereof. 

  

	 	(d)	Where any agreement for the purchase of electricity and/or chilled water supplied to all air-conditioning fan coil units and any other services supplied (whether entered into by
the Landlord or the Tenant) Is terminated for reasons not due to the default of the Landlord, the Landlord shall not be liable to compensate the Tenant for any loss or damage occurring to the Tenant as a result of such termination, including any
economic loss and/or loss of revenue, profits, business and/or custom. 

  

	2.	Not to object to any Designated Supplier. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -35- 

	3.	Without affecting the provisions of Clause 1 of Schedule 7 above, the Landlord may, at its discretion and on behalf of the tenants of the Building, arrange for the purchase of bulk electricity for the Building from an
electricity retailer, in which case, the Tenant must accept the Landlord’s choice of electricity retailer, and sign all relevant agreements, consents and/or authorisation forms as may be required by the Landlord for the purpose. If at any time
thereafter, the Landlord’s arrangement for the purchase of bulk electricity for the Building is terminated for any reason whatsoever, the Landlord shall notify the Tenant in writing of such termination and; 

 

	 	(a)	The Tenant must arrange for and procure its own supply of electricity to the Premises; and 

  

	 	(b)	The Landlord shall not be liable to compensate the Tenant for any loss or damage occurring to the Tenant as a result of such termination, including any economic loss and/or loss of revenue, profits, business and/or
customers. 

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -36- 

 Schedule 8 

(referred to in Clause 3.3) 

Security Deposit 
 The Tenant hereby
covenants with the Landlord as follows: 
  

	1.	The Tenant shall deposit with the Landlord the sum equivalent to three (3) months’ Rent and Service Charge for the Demised Premises (the “Security Deposit”), which Security Deposit shall be
maintained at an amount equivalent to three (3) months’ Rent and Service Charge during the Term. 

  

	2.	The Security Deposit shall be held by the Landlord as security for the due performance and observance by the Tenant of all the covenants and provisions contained in this Tenancy Agreement and as security for any claim
by the Landlord at any time against the Tenant in relation to any matter in connection with the Demised Premises whether the tenancy is subsisting or not, and subject to any deductions to be made by the Landlord pursuant to the provisions of this
Tenancy Agreement, shall be repaid to the Tenant without interest within one (1) month from the date the Demised Premises duly repaired, cleaned, decorated and reinstated in accordance with the Tenant’s covenants in this Tenancy Agreement,
are returned to the Landlord. 

  

	3.	If the Tenant shall commit a breach of any of the provisions of this Tenancy Agreement, the Landlord shall be entitled but not obliged to apply the Security Deposit or any part thereof in or towards payment of moneys
outstanding or making good any breach by the Tenant or to deduct from the Security Deposit the loss or expense to the Landlord occasioned by such breach but without prejudice to any other rights or remedies which the Landlord may be entitled. If any
part of the Security Deposit shall be applied by the Landlord in accordance herewith, the Tenant shall on demand by the Landlord forthwith deposit with the Landlord the amount set-off by the Landlord from the
Security Deposit. Provided Always that no part of the Security Deposit shall without the written consent of the Landlord be set-off by the Tenant against any Rent, Service Charge or other sums owing to the
Landlord. 

  

	4.	If from time to time during the Term, the Rent or Service Charge is increased, the Security Deposit paid by the Tenant to the Landlord shall likewise be increased and the difference shall be paid within fourteen
(14) days of the Landlord’s notice requiring payment. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -37- 

 Schedule 9 

(referred to in Clause 3.4) 

Insurance 
 The Tenant hereby covenants
with the Landlord as follows: 
  

	1.	At the Tenant’s own cost and expense at all times during the Term to take out and keep in force in the joint names of the Landlord and the Tenant for their respective rights and interest a comprehensive public
liability insurance policy in an adequate amount or in such higher amounts as the Landlord may from time to time prescribe, in respect of any one occurrence, such policy shall be extended to include the Tenant’s legal liability for loss of or
damage to the Demised Premises (including all fixtures and fittings therein) and in this regard, the Tenant shall ensure that the relevant exclusion in the said public liability policy relating to the property in the care, custody or control of the
Tenant or any servant of the Tenant, be deleted entirely. 

  

	2.	All policies of insurance required to be effected by the Tenant shall be taken out with a reputable insurance company approved by the Landlord. 

 

	3.	On written demand at any time by the Landlord, to produce forthwith to the Landlord any policy of insurance which the Tenant is required to effect hereunder and the receipt for the last premium payable in respect of
such policy. Provided Always that nothing herein shall render the Landlord liable for the correctness or adequacy of such policies or for ensuring that they comply with all relevant legislation pertaining to insurance. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -38- 

 Schedule 10 

(referred to in Clause 3.5) 

Repair of Demised Premises 
 The Tenant
hereby covenants with the Landlord as follows: 
  

	1.	At all times to repair and to keep in a clean and good state of tenantable repair and condition (fair wear and tear excepted), the Demised Premises including the interior thereof, the flooring, interior plaster or other
surface material or rendering on walls and ceilings, fixtures therein, all doors, windows, glass, locks, fastenings, installations and fittings for light and power, the Conducting Media within and serving the Demised Premises, and to make good to
the satisfaction of the Landlord any damage or breakage caused to any part of the Demised Premises or to the Landlord’s fixtures and fittings therein by the bringing in or removal of the Tenant’s goods or effects or resulting from any
action or omission of the Tenant, its employees, independent contractors, agents or any permitted occupier. 

  

	2.	The obligations in this Schedule 10 extend to all improvements and additions to the Demised Premises and all Landlord’s fixtures, fittings and appurtenances of whatever nature affixed or fastened to the
Demised Premises. 

  

	3.	If any damage or injury is caused to the Landlord or to any person whomsoever directly or indirectly on account of the condition of any part of the interior of the Demised Premises (including flooring, walls, ceiling,
doors, windows, curtain wall and its related parts including fluorocarbon coating thereon and other fixtures), to be wholly responsible therefor and to fully indemnify the Landlord against all claims, demands, actions and legal proceedings
whatsoever made upon the Landlord by any person in respect thereof. In the interpretation and application of the provisions of this Schedule 10 the decision of the surveyor or architect of the Landlord shall be final and binding upon the
Tenant. 

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -39- 

 Schedule 11 

(referred to in Clause 3.6) 

Alterations and Additions 
 The Tenant
hereby covenants with the Landlord as follows: 
  

	1.	Not to make any alterations or additions to or affecting the structure or exterior of the Demised Premises or the appearance of the Demised Premises as seen from the exterior. 

 

	2.	Not to paint or make any additions or alterations or exert any force or load on the frame structure and all its related parts or to place or affix any structures or articles or materials thereon which would otherwise
render the warranty granted in favour of the Landlord in respect of such roof, walls, floor and structure null and void. 

  

	3.	Not without the prior written consent of the Landlord to make any other alterations or additions to the Demised Premises. For purpose of seeking the Landlord’s consent herein, the Tenant shall submit to the
Landlord all plans, layouts, designs, drawings, specifications and details of proposed materials to be used for any proposed alterations and additions. Alterations and additions for purpose of this Schedule 11 shall include but shall not be
limited to works relating to: 

  

	 	(a)	internal partitions, floors and ceilings within the Demised Premises; 

  

	 	(b)	electrical wiring, conduits, light fittings and fixtures; 

  

	 	(c)	air-conditioning installations ducts and vents; 

  

	 	(d)	fire protection devices; 

  

	 	(e)	all plumbing and gas installations, pipes, apparatus, fittings and fixtures; and 

  

	 	(f)	all mechanical and electrical engineering works. 

  

	4.	The Landlord shall be entitled to engage its architect, engineer or other consultant(s) for the purpose of: 

  

	 	(i)	considering the plans, specifications and materials relating to the proposed alterations or additions; and 

  

	 	(ii)	supervising all works carried out by the Tenant. 

 The fees and expenses of such architect,
engineer and consultant(s) incurred in connection therewith shall be borne by the Tenant and forthwith paid by the Tenant to the Landlord on demand. If the Tenant fails to make payment on demand, the Landlord may effect payment of the same and all
expenses so incurred by the Landlord together with Interest from the date of expenditure until the date they are paid by the Tenant to the Landlord, shall be recoverable from the Tenant as if they were rent in arrears. 

 

	5.	All alterations and additions to the Demised Premises shall only be carried out: 

  

	 	(a)	in the case of any installation works in respect of the air-conditioning and mechanical ventilation system, fire-fighting and alarm system, telecommunication, security and
closed-circuit television system and building automation system and any electrical engineering works, by specialist contractors nominated by the Landlord and separately employed by the Tenant in relation to the Tenant’s Works; and

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -40- 

	 	(b)	in all other cases by engineers or contractors appointed by the Tenant with the approval of the Landlord. 

  

	6.	All planning and other consents necessary or required pursuant to the provisions of any statute, rule, order, regulation or by-law for any alteration or addition to the Demised
Premises or any part thereof, shall be applied for and obtained by the Tenant at its own cost and expense. 

  

	7.	The Tenant shall carry out and complete all alterations and additions to the Demised Premises in accordance with plans, layouts, designs, drawings, specifications and using materials approved by the Landlord, in a good
and workmanlike manner in accordance with all planning and other consents referred to in paragraph 6, and in compliance with the reasonable requirements of the Landlord’s architect. 

 

	8.	The Tenant shall not install or erect any exterior lighting, shade, canopy or awning or other structure in front of or elsewhere outside the Demised Premises. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -41- 

 Schedule 12 

(referred to in Clause 3.7) 

Landlord’s right of inspection and right of repair 

The Tenant hereby covenants with the Landlord as follows: 
  

	1.	To permit the Landlord and its servants or agents at all reasonable times and by prior appointment with the Tenant to enter into, inspect and view the Demised Premises and examine their condition and also
to take a schedule of fixtures in the Demised Premises. 

  

	2.	If any breach of covenant, defects, disrepair, removal of fixtures or unauthorised alterations or additions shall be found upon such inspection for which the Tenant is liable then upon notice by the Landlord to the
Tenant, to execute all repairs, works, replacements or removals required within one (1) month (or sooner if required by the Landlord) after the receipt of such notice, to the reasonable satisfaction of the Landlord or its surveyor.

  

	3.	In case of default by the Tenant, it shall be lawful for workmen or agents of the Landlord to enter into the Demised Premises and execute such repairs, works, replacements or removals. 

 

	4.	To pay to the Landlord on demand all expenses so incurred with Interest from the date of expenditure until the date they are paid by the Tenant to the Landlord (such expenses and Interest to be recoverable as if they
were rent in arrears). 

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -42- 

 Schedule 13 

(referred to in Clause 3.8) 

Landlord’s right of entry for repairs etc 

The Tenant hereby covenants with the Landlord as follows: 
  

	1.	To permit the Landlord and the agents, workmen and others employed by the Landlord or by the Management Corporation or by the other tenants or occupiers of the Building at all reasonable times during and after normal
office hours on weekdays and Saturdays, after giving to the Tenant prior notice (but at anytime in any case which the Landlord or Management Corporation considers an emergency) to enter upon or gain access through the Demised Premises:

  

	 	(a)	to inspect, cleanse, repair, remove, replace, alter or execute any works whatsoever to or in connection with the Conducting Media and ancillary apparatus, easements or services referred to in paragraph 1 of Schedule
2; or 

  

	 	(b)	to effect or carry out any maintenance, repairs, alterations or additions or other works which the Landlord or the Management Corporation may consider necessary or desirable to any part of the Building or to the water,
electrical, air-conditioning and other facilities and services of the Building or to the Common Property or any fixtures, fittings or installations comprised in the Common Property; or 

 

	 	(c)	for the purpose of exercising any of the powers and authorities of the Landlord under this Tenancy Agreement; or 

  

	 	(d)	to comply with any obligation of repair, maintenance or renewal affecting the Demised Premises, the Building or the Common Property; or 

 

	 	(e)	to construct, alter, maintain, repair or fix anything or additional thing serving the Building or the adjoining premises or property of the Landlord, and running through or on the Demised Premises; or 

 

	 	(f)	in connection with the development of the remainder of the Building or any adjoining or neighbouring land or premises, including the right to build on or onto or in prolongation of any boundary wall of the Demised
Premises; 

 without payment of compensation for any nuisance, annoyance, inconvenience or damage caused to the Tenant subject
to the Landlord (or other person so entering) exercising such right in a reasonable manner. 
  

	2.	To furnish to the Landlord the names, addresses and contact telephone numbers of at least two (2) management staff (“Designated Employees”) who are in the employ of the Tenant and who would retain
possession of the keys to the Demised Premises on a twenty-four (24) hour basis, to enable the Landlord to contact such Designated Employees at any time in case of emergency where the Landlord of the Management Corporation requires entry upon
or access through the Demised Premises for any of the purposes mentioned in paragraph 1. Such Designated Employees shall forthwith on request of the 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -43- 

	 	
Landlord open up the Demised Premises to permit the Landlord or the Management Corporation and their agents and workmen entry upon or access through the Demised Premises for the above mentioned
purposes. The Tenant shall ensure that if any of the Designated Employees will be away from Singapore or leaves the employ of the Tenant or will in any circumstances be out of reach, the Tenant shall furnish to the Landlord the name, address and
contact telephone number of another employee of the Tenant who will fulfil the role of such Designated Employee. The Tenant shall immediately inform the Landlord of any change of telephone numbers and other particulars of each Designated Employee.
In the event that after reasonable attempt, the Landlord is unable to contact the Designated Employees at the telephone numbers furnished to the Landlord, and in any case which the Landlord or the Management Corporation considers an emergency, the
Tenant hereby authorises the Landlord to use all reasonable means necessary to force an entry into the Demised Premises, such forceful entry to be conducted under the supervision of the chief security officer or building manager employed for the
Building, and the Tenant hereby agrees that the Landlord shall not be liable to the Tenant, nor shall the Tenant have any claim whatsoever against the Landlord in respect of any damage to the Demised Premises to the contents therein or any
consequential loss arising from such forceful entry to the Demised Premises. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -44- 

 Schedule 14 

(referred to in Clause 3.9) 

Yield up in repair at the end of the Term 

The Tenant hereby covenants with the Landlord as follows: 
 At
the expiration or earlier determination of the Term: 
  

	1.	To surrender to the Landlord all keys giving access to all parts of the Demised Premises irrespective of whether or not the same have been supplied by the Landlord. 

 

	2.	Quietly to yield up the Demised Premises in the Bare and Original Condition (fair wear and tear excepted) to the satisfaction of the Landlord (after removal of all additions and improvements made by the Tenant to
the Demised Premises and all fixtures which may be fixed or fastened to or upon the Demised Premises by the Tenant), repaired, cleaned, decorated and kept in accordance with the Tenant’s covenants contained in this Tenancy Agreement.

  

	3.	To remove from the Demised Premises all additions, improvements, fixtures and fittings installed by the Tenant and all notices, notice boards and signs bearing the name of or otherwise relating to the Tenant (including
in this context any persons deriving title to the Demised Premises under the Tenant) or its business. 

  

	4.	Without prejudice to the generality of the provisions of paragraphs 2 and 3, to reinstate all air-conditioning installations, sprinkler systems and other electrical and electronic
installations therein to their bare and original state as at the date the Tenant took possession of the Demised Premises to the satisfaction of the Landlord, such reinstatement to be carried out by a specialist contractor nominated by the Landlord
and appointed by the Tenant, under the supervision of the Landlord’s architect, engineer or consultant and the Tenant shall pay for all fees of such architect, engineer or consultant. In all other cases, the removal and reinstatement works in
respect of the Demised Premises shall be carried out to the satisfaction of the Landlord. 

  

	5.	To redecorate the Demised Premises to the satisfaction of the Landlord, with two coats of good quality emulsion paint and other appropriate treatment of all internal parts of the Demised Premises including the ceiling
and floor in a good workmanlike manner using suitable and appropriate materials as the Landlord may reasonably and properly require. 

  

	6.	To make good to the satisfaction of the Landlord all damage to the Demised Premises and the Building resulting from the removal of the Tenant’s belongings, reinstatement or redecoration of the Demised Premises.

  

	7.	Where clause 4.3.2 is applicable, quietly to yield up the Exclusive Use Common Areas in the Bare and Original Condition (fair wear and tear excepted) to the satisfaction of the Landlord (after removal of
all additions and improvements made by the Tenant to the Exclusive Use Common Areas and all fixtures which may be fixed or fastened to or upon the Exclusive Use Common Areas by the Tenant), repaired, cleaned, decorated and kept in
accordance with the Tenant’s covenants contained in this Tenancy Agreement. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -45- 

	8.	If the Tenant fails to remove the fixtures and fittings, reinstate, redecorate or make good any damage to the Demised Premises and Exclusive Use Common Areas in accordance with the provisions of this Schedule
14, the Landlord may effect the same at the Tenant’s cost and expense Provided that the Landlord shall carry out such works within a reasonable period and all costs and expenses incurred by the Landlord together with the Rent and Service
Charge which the Landlord shall be entitled to receive had the period within which such works effected by the Landlord been added to the Term, shall be paid by the Tenant within seven (7) days of demand from the Landlord, and in this
connection, a certificate of the Landlord as to the amount of cost and expenses incurred shall be conclusive and binding on the Tenant. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -46- 

 Schedule 15 

(referred to in Clause 3.11) 

Covenants affecting use of Demised Premises and Building 

The Tenant hereby covenants with the Landlord as follows: 
  

	1.	Not to erect nor install in the Demised Premises any machinery which causes noise, fumes or vibration which can be heard, smelled or felt outside the Demised Premises. 

 

	2.	Not to store in the Demised Premises any petrol or other specially inflammable, explosive or combustible substance. 

  

	3.	Not to use the Demised Premises for any noxious, noisy or offensive trade or business nor for any illegal or immoral act or purpose. 

 

	4.	Not to hold any sales by auction on the Demised Premises. 

  

	5.	Not to hold in or on the Demised Premises any exhibition, public meeting or public entertainment. 

  

	6.	Not to permit any vocal or instrumental music in the Demised Premises so that it can be heard outside the Demised Premises. 

  

	7.	Not to permit livestock of any kind to be kept on the Demised Premises. 

  

	8.	Not to do in or upon the Demised Premises anything which may be or may become or cause a nuisance, annoyance, disturbance, inconvenience or damage to the Landlord or its other tenants of the Building or to the owners,
tenants and occupiers of adjoining and neighbouring properties. 

  

	9.	Not to load, paint or make alterations or additions to or use the floors, walls, ceilings, claddings, curtain wall, its frame structure and its related parts including the fluorocarbon coating thereon or the structure
of the Demised Premises in any manner which will cause strain, damage or interference with the structural parts, loadbearing framework, roof, foundations, joists, curtain wall and its related parts and external walls of the Demised Premises or in
any manner which will render any related warranties granted in favour of the Landlord null and void and without prejudice to the generality of the foregoing, not to load or permit or suffer to be loaded on any part of the floors of the Building or
the Demised Premises to a weight greater than 4.5 KN/m2 (or such other weight as may be prescribed by the Landlord as being applicable to the Demised Premises) and, when required by the Landlord, to distribute the load on any part of the floor of
the Demised Premises in accordance with the directions and requirements of the Landlord and in the interpretation and application of the provisions of this paragraph 9, the decision of the surveyor, architect or engineer of the Landlord shall be
final and binding on the Tenant. 

  

	10.	To obtain the prior written consent of the Landlord before bringing upon the Demised Premises any heavy machinery or other plant, equipment or goods with an imposed load in excess of 4.5 KN/m2 (or such other weight as
may be prescribed by the Landlord as being applicable to the Demised Premises). The Landlord may direct the routing, installation and location of all such machinery, plant, equipment and goods and the Tenant shall comply with all such directions,
and shall make good and indemnify the Landlord in respect of any damage to the Building caused by the bringing in of such machinery, plant, equipment or goods. 

  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -47- 

	11.	Not to overload the lifts, electrical installation or Conducting Media in the Demised Premises and/or the Building. 

  

	12.	Not to do or omit to do anything which interferes with or which imposes an additional loading on any ventilation, air-conditioning or other plant or machinery serving the
Building. 

  

	13.	Not to do anything whereby any policy of insurance on including or in any way relating to the Demised Premises taken out by the Landlord or the Management Corporation may become void or voidable or whereby the rate of
premium thereon or on the remainder of the Building may be increased, but to provide one or more efficient fire extinguishers of a type approved by the Landlord and to take such other precautions against fire as may be deemed necessary by the
Landlord or its insurers. 

  

	14.	Not to allow any person to sleep in the Demised Premises nor to use the Demised Premises for residential purposes. 

  

	15.	Not without the prior written consent of the Landlord to permit the vendors of food or drink or the servants or agents of such vendors to bring to or onto the Demised Premises or any part thereof or onto the Building or
any part thereof food or drink for consumption by the occupiers or others in the Demised Premises save and except in the case of the contractor who has been given the right by the Landlord to provide a food and drink service for the occupiers of the
Building. 

  

	16.	To keep the Demised Premises and every part thereof clean and in the fullest possible hygienic condition and to keep all pipes, drains, basins, sinks and water-closets in the Demised Premises clean and unblocked. The
Tenant shall not employ in or about the Demised Premises any cleaner other than the cleaning contractor approved by the Landlord to carry out the cleaning work for the Building and the Tenant shall not have any claim against the Landlord in respect
of any act, omission or negligence of such cleaner in or about the performance or purported performance of his duties. 

  

	17.	To keep the Demised Premises free of pests, rodents, vermin and insects. 

  

	18.	To keep the windows of the Demised Premises closed at all times and not to erect or install any sign, device, furnishing, ornament or object which is visible from the street or from any other building and which, in the
opinion of the Landlord, is incongruous or unsightly or may detract from the general appearance of the Building. 

  

	19.	To ensure that the decor and design of the exterior of the Demised Premises are in accordance with plans and specifications previously submitted to and approved by the Landlord, and not to make any changes to such
external parts without the prior written consent of the Landlord. 

  

	20.	To ensure that all doors of the Demised Premises are safely and properly locked and secured when the Demised Premises are not occupied. 

 

	21.	Not to cover or obstruct or permit to be covered or obstructed in any manner or by any other article or thing (other than window blinds approved by the Landlord), the windows,
sky-lights or ventilating shafts or air inlets or outlets which reflect or admit light or enable air to flow into or out of the Demised Premises or any part of the Building. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -48- 

	22.	Not to throw, place or allow to fall or cause or permit to be thrown or placed in the lift shafts, water-closets or other conveniences in the Building any sweepings, rubbish, waste paper or other similar substances, and
the Tenant shall on demand pay to the Landlord the costs of repairing any damage to such lift shafts, water-closets or other conveniences arising therefrom. 

  

	23.	Not to permit or cause to be permitted the placing or parking of bicycles, motor cycles or scooters, trolleys and other wheeled vehicles and/or the stocking or storage or littering of goods or things in the common parts
of the Building, the corridors, passageways, pavements and the car-parking areas and to keep all such internal and external parts of the Building clear and free of all obstruction at all times.

  

	24.	Not to place or take into the passenger lifts any baggage, furniture, parcels, sacks, bags, heavy articles or other goods or other merchandise save only such light articles as brief-cases, attache cases and handbags and
to use only the service lift prescribed by the Landlord for the transportation of furniture, goods and other heavy equipment. 

  

	25.	Not to permit or allow food trays and tiffin carriers to be brought into or carried in any passenger lift and the Tenant shall ensure that such items are conveyed in the service lift only. 

 

	26.	Not to permit or allow the contractors, workmen or cleaners (with or without equipment and tools) engaged by the Tenant to use the passenger lifts of the Building and to ensure that they use only the service lift
prescribed by the Landlord. 

  

	27.	Not to solicit business, display or distribute advertising material in the car parks or other common areas of the Building. 

  

	28.	Not to employ or otherwise engage any foreigner unless he or she holds a valid work permit or employment pass permitting him or her to work at the Demised Premises and without prejudice to the generality of Clause 3.14,
not to use, permit or suffer the Demised Premises to be kept or used as a place or premises in which any person is employed in contravention of Section 57(1)(e) of the Immigration Act (Cap 133) or any statutory modification or re-enactment thereof for the time being in force and to indemnify the Landlord against all costs, claims, liabilities, fines or expenses whatsoever which may fall upon the Landlord by reason of any non-compliance thereof. 

  

	29.	To observe and perform or cause to be observed and performed the rules and regulations from time to time made by the Landlord or the Management Corporation in connection with the orderly and proper use of the lobbies,
corridors, staircases, lifts, hoists, lavatories and other parts in common use in the Building and access ways and service areas to the Building and also in connection with the security of the Building. 

 

	30.	Maintenance and cleaning of toilets and common areas 

 (only applicable to full wing Tenant)

 Notwithstanding Clause 4.3.1 (iii), in the event that the Demised Premises consists of one (1) whole wing of the floor, the Tenant shall
be responsible at its own costs and expenses for the maintenance and cleaning of the toilets and common areas (including but not limited to the pantry areas) serving the Demised Premises exclusively. 

 
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -49- 

 Schedule 16 

Provisions of Renewal 
  

	1.	The Landlord shall at the written request of the Tenant between six (6) to nine (9) months before the expiration of the Term and if there shall not at the time of such request be any existing breach or non-observance of any of the covenants on the part of the Tenant herein contained and at the Tenant’s expense grant to the Tenant a further term (“Renewed Term”) of the Demised Premises.

  

	2.	The Renewed Term shall be for a term specified in paragraph 12 of Appendix A and upon the same terms and conditions as are contained in this Agreement save that this option to renew clause shall be excluded and at a
revised rent to be mutually agreed provided that :- 

  

	 	(i)	the Tenant shall have strictly and faithfully performed and observed all and singular the several stipulations contained in this Agreement during the Term and there is no existing breach of this Agreement as at the time
of the Lessee’s notice of renewal; and 

  

	 	(ii)	the Tenant gives the Landlord notice in writing made not less than six (6) months prior to the expiry of the said Term (“the Renewal Notice”) of the Tenant’s intent to exercise this Option to Renew
and signs and delivers the lease agreement for the Renewed Term to the Landlord not less than six (6) months prior to the expiry of the said Term. 

  

	3.	Provided Always that within two (2) weeks of the receipt of the Landlord’s proposal for the revised rent and the proposed covenants and provisions, the Tenant shall in writing inform the Landlord whether the
revised rent, covenants and provisions is or are acceptable or otherwise. 

  

	4.	In the event that the revised rent or the proposed covenants and provisions is or are not acceptable to the Tenant or if the Tenant fails to give any written unconditional acceptance to the Landlord within the aforesaid
two week period, then it shall be deemed that the Tenant is no longer interested in renewing the tenancy and the Landlord shall be free to terminate all negotiations with the Tenant for the renewal of the tenancy. 

 

	5.	If the Landlord’s proposal for the revised rent, covenants and provisions has been accepted by the Tenant within the aforesaid two week period, the Tenant shall sign the new tenancy within two weeks of receipt of
the new tenancy documents. 

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -50- 

 Annexure A 

Plan of Demised Premises 
  

 
 Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -51- 

 

 

 IN WITNESS WHEREOF the parties have entered into this Tenancy Agreement the day and year first above
written. 
  

							
	 Landlord
  

SIGNED BY
  

for and on behalf of UNITED
  

ENGINEERS LIMITED in the presence of:
	  	

	  		  	
				
		  		  	             /s/ Goh Yiow Kuang
	  	
		  		  	 Name: Mr Goh Yiow Kuang
  

Designation: General Manager
	  	
				
	  

            /s/ Quek Jing Yi
	  		  	 

	  	
	 Name of Witness: Ms Quek Jing Yi
  

Designation: Head, Corporate Leasing
	  	  	  
				
	 Tenant
  

SIGNED BY
  

for and on behalf of ASLAN
  

PHARMACEUTICALS PTE LTD
  

in the presence of:
	  	

	  		  	
			
		  		  	             /s/ Carl
Firth

		  		  	 Name:                Carl Firth

                          
 CEO
 Designation:      ASLAN Pharmaceuticals
  

Tenant’s company stamp:
	  	

	 /s/     Nishi Singh
	  		  		  
	 Name of Witness: Nishi Singh
  

NRIC No:
  

Occupation: Legal Manager
	  		  		  	

  
  

Tenant: M/s Asian Pharmaceuticals Pte Ltd 

  
 -52-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}]]